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OVERVIEW OF RELATED LITERATURE

Introduction
Candida albicans is an opportunistic pathogen with a
wide range of infectious capabilities.

Infections vary from

localized to systemic, and are potentially fatal.
immune response to
of

~.

~-

The

albicans varies directly with the type

albicans infection.

Localized infections are

controlled by polymorphonuclear leukocytes (PMNs) and later
by macrophages (Smith, 1985).

Deep seated infections are

contained by PMNs as well (Wilton and Lehner, 1981).
However, multiple cell populations have been implicated in
the immune response to systemic fungal infection, including
T lymphocytes (Mahanty et al., 1988).

The evidence for

absolute involvement of any one effector population is
inconclusive.

Animal models with genetic defects in various

lymphoid populations have failed to elucidate a precise
anti-~.

albicans mechanism (Mahanty et al., 1988).

Therefore, it is possible that alternative cell populations,
activated by the immune response to

~.

albicans, may be

responsible for and contribute to the actual immunological
and protective response to

~.

albicans.

1

2

immune Response to C. albicans.
Host defense against infection with

~.

albicans is

mediated by both phagocytic cells and aspects of classical
cell-mediated immunity (Mahanty et al., 1988).

Other immune

cell populations have also been assessed for their role in
host defense activity against

~.

albicans including B

lymphocytes (Smith, 1985) and natural killer (NK) cells
(Zunino and Hudig, 1988).

However, the relative

contribution of each cell population in protection against
specific forms of candidiasis remains to be elucidated.

A. Role of phagocytic cells
Invasive infections of

~.

albicans are the result of

hyphal forms which are too large to be ingested by
phagocytic cells but have been shown to be damaged by them
via extracellular mechanisms (Diamond and Haudenschild,
1981; Hurtrel et al., 1980; Diamond and Krzesicki, 1978).
The proposed anti-fungal mechanisms for these cells are the
production of reactive oxygen intermediates such as hydrogen
peroxide, super oxide anion, hydroxyl radical, and singlet
oxygen (Nathan et al., 1983).

Oxygen-independent killing of

macrophages against a variety of targets has been attributed
to a number of secreted substances including arginase,
cytolytic protease, thymidine, complement cleavage products,
macrophages cytotoxin, lysosomal cationic proteins, and
tumor necrosis factor (Smith, 1985; Cleary and Marciano-

3

Cabral, 1986).

As a consequence, these cells have been

implicated as the primary means by which invasive infections
of

~·

albicans are limited (Ashman and Papadimitriou, 1987) .

Further evidence for the important role of phagocytic cells
comes from studies in which T lymphocyte-deficient nude mice
were found to be relatively more resistant to infection than
normal animals due to increased macrophage activity (Rodgers
and Balish, 1980).

Despite the decrease in T lymphocyte

activity, nude mice possess an enhanced NK activity and a
normal level of lymphokine activated killer (LAK) cell
activity (Hasui et al., 1989).

Therefore, the resistance to

infection in nude mice may not be an exclusive consequence
of increased macrophage activation.

It is possible that

alternative cell populations, such as NK and LAK, may serve
to mediate host protection against the fungus in the nude
mouse as well as in the normal host environment.

B. Role of T cells
Thymus-dependent, cell-mediated immunity provides
protection against

~.

albicans as evidenced by enhanced

susceptibility to candidiasis in thymectomized mice (Mahanty
et al., 1988).

Further evidence is displayed by patients

with chronic mucocutaneous candidiasis (Wilton and Lehner,
1981), malignancies (Bodey, 1986), and immunodeficiency
syndromes (Smith, 1985), who often display defective
delayed-type hypersensitivity (DTH) reactions to

~.

albicans

4

antigen.

T lymphocytes from a majority of these patients

show no responsiveness to g. albicans antigen

in vitro

(Odds, 1979) •
In addition to the DTH response, Cenci et al. (1989)
have suggested an important role for inflammatory L3T4+
lymphocytes as a cofactor of phagocytic cell activation.
The loss of L3T4+ lymphocytes significantly reduced host
resistance to g. albicans as judged by DTH responsiveness,
lymphokine production, and survival (Cenci et al., 1989).
Cenci et al. (1989) have postulated that immune L3T4+ T
lymphocytes contribute to protective immunity against
systemic g. albicans infection through the secretion of
cytokines which activate cells with candidacidal activity.
However a portion of animals possess the capacity to survive
following L3T4+ lymphocyte depletion.

The authors suggest

alternative mechanisms may provide protection under
conditions for which the activity of this T lymphocyte
subset is reduced.

c. Role of B cells
A role for B lymphocytes in protection against fungal
infection is not established (Hector et al., 1982).
Although some host protection can be transferred with immune
serum, B lymphocytes and their products play a minor role in
the protective host response to
al.

I

1980) •

~.

albicans (Piccolella §.t

5

o.

Role of natural killer cells
Natural killer (NK) cells have been shown to interact

with certain fungi.

In vitro, cells with both functional

and phenotypic characteristics of NK have been shown to bind
to and inhibit the growth of Cryptococcus neoformans as well
as to inhibit the growth of Paracoccidiodies brasiliensis
(Nabavi and Murphy, 1985; Murphy and McDaniel, 1982; Jimenez
and Murphy, 1984). In vivo, NK have been shown to mediate
growth inhibition of cryptococcus neoformans (Hidore and
Murphy, 1986).

Other investigators have failed to

demonstrate human NK anti-fungal activity against g.
albicans (Djeu and Blanchard, 1987) .

Those investigators

found that enriched human LGL possessed no innate activity
against g. albicans.

The LGL population could not be

activated by low levels of IL-2 to inhibit g. albicans
growth although cytotoxicity for the human NK susceptible
tumor cell line K562 was enhanced.

Activated LGL supernate

contained the capacity to enhance PMN function against g.
albicans.

These data suggest that this LGL population did

not mediate direct anti-g. albicans activity but rather
functioned in an indirect manner by inducing the release of
TNF which then activated PMN anti-g. albicans activity (Ojeu
et al., 1988).
NK cells do not appear to have a major role in
resistance to murine g. albicans infections (Vecchiarelli et
al., 1985).

Isolated splenic NK cells show no direct anti-

6

g. glbicans inhibitory activity which suggests that NK may
not mediate destruction of yeast species other than
cryptococci (Zunino and Hudig, 1988).
severe combined immunodeficient (SCIO) mice have no
detectable levels of immunoglobulins in their serum and
their mature T and B lymphocytes are markedly reduced in
number or even absent (Hasui et al., 1989).

Mice homozygous

for SCIO gene possess normal macrophage activity and an
expanded pool of natural killer cells with normal functional
activity (Lauzon et al., 1986).

Comparisons of homozygous

SCIO to heterozygous SCIO (phenotypically normal) BALB/c
mice show no difference in the recovery of g. albicans from
organs following infection.

This observation suggests that

a non-T, non-B lymphocyte may mediate anti-fungal activity
(Mahanty et al., 1988).

The exact role of T lymphocytes is

unclear as both athymic nude mice and T lymphocyte deficient
SCIO mice both possess normal or enhanced activity against

g. albicans which is in contrast to studies demonstrating a
T lymphocyte requirement for immunity.

Whether the

protection is mediated by activated macrophages or by an
activated lymphocyte population is unknown.

Both nude mice

and SCIO mice possess normal LAK activity (Hasui et al.,
1989) .

Infection with Candida and

c.

albicans.

A. Virulence of Candida and g. albicans

7

Although antigenic variation of

~.

albicans and

variation in virulence have been described (Ausiello et al.,
198 9), it is changes in the host which contribute most to
susceptibility to infection with
Lehner, 1981; Meunier, 1989).
are pathogenic, including

~.

~-

albicans (Wilton and

Numerous species of candida
albicans, Candida tropicalis,

Candida krusei, and Candida parapsilosis.

In general,

~.

glbicans is the species most associated with invasive
candidiasis following fungemia (Meunier, 1989).

Invasive or

systemic candidiasis has a mortality rate of over 70% in
immunosuppressed patients and is difficult to both diagnose
and treat (Matthews and Burnie, 1989).
Systemic candidiasis is the most serious form of
candidiasis.

It is recognizable by invasive infection

involving the parenchyma of two or more visceral organs
including heart, kidney, spleen, lung, and brain among
others.

Histologically, the lesions in systemic candidiasis

resemble small abscesses composed of a mixture of PMNs and
mononuclear cells (Luna and Tortoledo, 1985).

B. Candidiasis in immunosuppressed patients
A variety of immunocompromised patients are susceptible
to Candida infections.

A number of factors contribute to

the increasing frequency of fungal infections in these
patients.

In patients with cancer undergoing combination

chemotherapy, the patient becomes debilitated, malnourished

8

and host defense mechanisms are impaired.

The patients

become highly susceptible to infection and resistant
microorganisms, such as fungi, can cause superinfection
(Bodey, 1966).

Fungal infections are especially prevalent

among children with acute lymphocytic leukemia who
experience prolonged periods of neutropenia due to the
disease or its therapeutic treatment (Gold, 1984).
Infections caused by Candida species are the most common
fungal diseases in immunocompromised patients (Hawkins and
Armstrong, 1984).

Fungi cause 21% of the fatal infections

in patients with acute leukemia, 13% in patients with
lymphoma, and 6% in patients with solid tumors (Bodey,
1986).

Candida spp. account for a majority of serious

fungal infections with Candida albicans the most frequent
pathogen (Ashman et al., 1990).
Other prime candidates for life-threatening invasive
candidal infections are those with defects in normal immune
function, in particular patients with chronic granulomatous
disease.

Persons with profound defects in cell-mediated

immunity, such as transplant recipients, patients with
acquired immunodeficiency syndrome, and patients receiving
chronic steroid therapy are also at significant risk of
invasive candidal infection.

Finally, therapeutic

maneuvers, such as antibiotics and steroids, that compromise
normal mucocutaneous barriers to infection will enhance

~.

albicans colonization and predispose patients to systemic

9

candidiasis (Meunier, 1989).

Binding of

c. albicans to Host Tissue.

A primary concern of the host immune response to g.
albicans is the mechanism by which the fungus attaches to
host tissues.

An understanding of the mechanisms which

permit g. albicans to colonize host tissue may allow a
further understanding of the immune recognition of g.
albicans.

The cell surface of this organism has been

investigated because of its perceived role in virulence.
The cell wall is composed of several layers and includes the
major antigens of the yeast cell.

The cell undergoes

significant compositional changes during conversion of yeast
form to the hyphal form (Reiss et el., 1986).

This

phenomenon is associated with the invasiveness of the
organism.
Adherence of g. albicans to the mucosal epithelial
cells is an important initial step in the process of
colonization and invasion.

Hydrophobic interactions of the

cell wall with the endothelium are believed to be important
in g. albicans binding to target tissues (Hazen, 1989).
Apical growth and elongation as a compartmentalized tube
allows for invasion of epithelial cells by direct
penetration of the epithelial cell membrane (Braun and
Calderone, 1978).

10
oespite the utilization of hydrophobic interactions, a
more detailed mechanism for binding of
cell populations is unknown.
shown that

~.

~.

albicans to other

Bouchara et al. (1990) have

albicans in the hyphal form, possess germ tube

specific receptors for laminin which mediate its attachment
to basement membrane.

Laminin is a multifunctional

glycoprotein which promotes the adhesion of various
eucaryotic cell types in vitro.

Specifically, laminin

receptors have been found on cells that normally interact
with basement membrane (Yannariello-Brown et al., 1988), as
well as on cells that extravasate, such as tumor cells,
granulocytes, lymphocytes and macrophages.

Basement

membranes are normally unexposed in vivo, with the exception
of the endothelia of kidney glomeruli to which candidal
infections seed thus serving as a source of dissemination in
systemic candidiasis.
The location of the laminin receptor on
been specified by electron microscopy.

~.

albicans has

The receptor is

connected to the outer f ibrillar layer of the hyphal cell
wall.

The receptor is not found on the yeast form nor on

the mother cell of the hyphae.
was saturable and specific.

The binding of the hyphae

Two types of receptors were

found. The first had a molecular mass of 68 kilodalton {kD)
which is similar to laminin receptors previously described
on different cell types including tumor cells and
endothelial cells (Rao et al., 1983; Yannariello-Brown et

11
al., 1988). The second receptor was a doublet of 60 and
-kD,
which may correspond to a degradation product of the

62

first as found in tumor cell lines (Graf et al., 1987).
The doublet may also be related to previously described

g. albicans proteins.

Calderone et al. (1988) found that by

further separating 70 and 62 kD proteins isolated from

~

albicans cell wall on high-performance liquid chromatography
that complement component C3d receptor could be isolated at
60 kD.

The complement component C3d fragment has also been

found to bind exclusively to the hyphal form of
(Eigentler et al., 1989).

~.

albicans

Another possible explanation is

that the 68 and 60/62 doublet are related to other adhesion
molecules.

Tronchin et al. (1988) isolated four proteins

which are involved in the adherence of
plastic.

~.

albicans hyphae to

The two major proteins involved in binding were 68

and 60 kD.

Either similar proteins or functions of the same

proteins are involved.
Bouchara et al. (1990) found that the same components
of 68 and 60 kD which bound laminin also bound another
common basement membrane protein, f ibrinogen, and to some
extend the complement component C3d.
reduced the binding of laminin to

~.

Fibrinogen, greatly
albicans, suggesting

that binding of f ibrinogen leads to a stearic hindrance of
the laminin receptors or that binding of these two host
proteins to hyphae may be by the same receptor (Bouchara et
al., 1990).

Fibronectin, bovine serum albumin,

12

transferrin, and multiple oligosaccharides did not bind the
iaminin receptor indicating a degree of specificity.
However, the capacity of the receptor to bind unrelated
proteins suggests multiple biological activities for the
receptor.

The molecular mechanism of recognition of these

unrelated host proteins by the same g. albicans receptors
remains unclear.
~·

These data do suggest that attachment of

albicans hyphae to tissue and cell surf aces may correlate

with the presence of an extracellular matrix component which
mediates binding to the hyphal surface.
Due to the role phagocytic cells play in the clearance
of g. albicans, multiple studies have assessed the mechanism
by which these effector populations bind the fungus.

The

state of the phagocytic cell, the presence or absence of
serum components, and the physiological state of g. albicans
are contributing factors to cellular recognition and binding
(Houston and Douglas, 1989).

The best characterized

interaction is that of rat alveolar macrophages which bind

g. albicans through a mannose/N-acetylglucosamine receptor.
This receptor is demonstrable on human peripheral blood
mononuclear cells (PBMC) which were cultured in vitro for
three days without lymphokines.

Fresh PBMC however, do not

possess the receptor (Stahl et al., 1980).
Consideration must be given to the physiological state
of g. albicans during the binding process.

Growth in

enriched media or within the host increases the production

13

of the outer fibril layer.

An increase in the fibril layer

will increase both the adherence and virulence of
~bicans.

Phagocytic cells appear to recognize

~.

~.

albicans

by lectin-carbohydrate interactions which promote strong
attachment following increased fibril production (Houston
and Douglas, 1989).
attachment of

~.

Lectin-like interactions mediate

albicans to vaginal and buccal cells via

mannoprotein fibrils on the outer cell envelope (Critchley
and Douglas, 1987).

The fibrils also promote binding to

PMNs as well as alveolar and peritoneal macrophages by a
related mechanism (Warr, 1980; Kolotila et al., 1987).
Furthermore, macrophage binding to yeast depends on a
lectin-like macrophage receptor specific for glycoproteins
terminating in mannose or fucose residues (Stahl and Gordon,
1982).
The binding is not believed to be mediated by specific
receptors but rather by a variety of factors such as the
activation state of the cell in combination with the state
of the host and the time course of the infection (Houston
and Douglas, 1989).

Most likely, the activated phagocyte

recognizes a component of the cell wall through either
lectin-type interactions, or sugar residues before
activating its extracellular cytotoxic machinery.

A similar

recognition mechanism is possible for other non-specific
effector populations.
Hidore and Murphy (1989) evaluated the binding of NK
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cells to cryptococcus neoformans.

They found both

similarities and differences in the physical and kinetic
binding and growth inhibition of cryptococci compared with
binding and lysis of tumor targets.

Electron microscopy

studies demonstrated that in contrast to the broad area of
interdigitating membrane contact observed in NK cell-tumor
cell conjugates, the contact area of NK cell-cryptococci
conjugates is much smaller, does not appear to
interdigitate, and is less intimate (Murphy, 1989).
found binding to be Mg2 + dependent.

They

Growth inhibition was

ca2+ and temperature dependent for both fungal and tumor
targets.

Murphy therefore suggests a similar recognition

and effector mechanism for cryptococci and tumor cells.

The

structural differences between the fungal and tumor cell
target would still permit intimate cell to cell interaction.
The investigation of Murphy (1989) did not identify the
mechanism by which NK recognizes, binds, and mediates its
effect on

~.

neoformans.

Despite the binding and cytotoxic

activity demonstrated against the cryptococci, NK cells do
not possess
1985).

anti-~.

albicans activity (Vecchiarelli et al.,

However, Zunino and Hudig (1988) found that

~.

albicans inhibited the binding of NK cells to K562 tumor
targets.

Immunoregulation of
A.

c.

albicans Infection.

Suppression of the immune response
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ouring infection, Q. albicans itself may both upregulate and down-regulate the immune system.

Neutrophil

function was shown by Diamond and Haudenschild (1981) to be
impaired by substances liberated from hyphae of Q. albicans.
Normal T-lymphocyte functions may also be impaired during
the course of Q. albicans infections.

The lack of T-cell

reactivity to Q. albicans antigens, a characteristic of
patients with chronic mucocutaneous candidiasis, was noted
by Valdimarsson et al. (1973) to be occasionally reversed
when the infection was controlled, thus suggesting the
fungal infection induced the abnormality in lymphocyte
function.

Evidence of immunosuppression includes a decrease

in the in vivo response to the common skin test antigens and
suppressed in vitro proliferative responses to Q. albicans
antigens {Cuff et al. 1989).

Stobo et al. (1976) found

generalized abnormalities in T-cell recognition of fungal
antigens in infected patients and showed that the
abnormality was due to the generation of suppressor T
lymphocytes.

Cuff et al., (1989) have described the

suppressor cell to be Thy-1+, Lyt-1+, Lyt-2-, and L3T4+.
Others have found the suppressor population to be cos+ or
even a B lymphocyte population (Domer, 1989).

The mediator

of suppression appears to reside in the cell wall
polysaccharide, mannan, although its exact makeup is unknown
(Podzorski et al., 1990).

The observed immunosuppression

has been proposed to be due to factors released during the
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yeast to hyphae transition of

~.

albicans (Cockayne and

odds, 1984).

B. Activation of the immune response
In murine models, it has been shown that inoculation of
live or inactivated
of the

~·

~.

albicans cells or purified components

albicans cell wall, can modulate the activity of

the immune system.

Components of other microorganisms have

been shown to activate

MHc~unrestricted

cell cytotoxicity

(Tarkkanen et al., 1986; Bonavida et gl_., 1986).

~.

albicans induces strong anti-tumor responses in mice
infected with heat-killed yeast and hyphae from

~.

albicans

(Kohoshis et al., 1978; Marconi et al., 1985).

These

responses are also induced by inoculating mice with either
of the two primary components of the cell wall of
albicans, mannoprotein (GMP) or glucan (GG).

~.

NK and

macrophage effectors are activated following administration
of either component.

GMP also induces lymphoproliferation

and production of gamma interferon as well as the generation
of cell-mediated cytotoxicity in PBMC (Ausiello et al.,
1988).

GMP induced lytic effectors are similar to IL-2

induced lytic effectors in potency, target specificity, and
type of precursor cells.

These data suggest that cytokines

produced in response to the infection are involved in
nonspecific anti-microbial resistance induced by
(Vecchiarelli et al., 1989).

~.

albicans
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~ariability

in the Murine Immune Response to

c.

albicans.

The C57Bl/6 mouse is highly resistant to challenge with
~·

albicans.

Other inbred murine strains are much more

susceptible to the fungus {Marquis et g_l., 1986).

The

differential susceptibility between murine strains is not
solely due to differences in phagocytosis and/or splenic
clearance of the microorganism.

Various murine strains

such as C57Bl/6 (high resistance), BALB/c (intermediate
resistance), and CBA/H (low resistance) show no correlation
between survival following £. albicans challenge and either
of those biological activities (Ashman and Papadimitrou,
1987).

SCID mice, deficient in T and B lymphocytes, possess

macrophage activity which is not significantly different
from corresponding inbred strains (Hasui et al., 1989).
Nude mice and mice which have been thymectomized, lethally
irradiated, and bone marrow reconstituted show no difference
in macrophage activity or clearance of

£. albicans when

compared to normal mice (Ashman and Papadimitrou, 1987).
A correlation does exist between the production of
cytokines and the development of resistance to the fungus
within murine strains.

Neta and Salvin (1983) reported that

the release of lymphokines from mice following sensitization
with cell walls of

£. albicans was under genetic control.

They found the capacity of a murine strain to release
cytokines in vivo parallels the capacity of that strain to
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resist i.v. infection with g. albicans.

g. albicans

infected strains of mice which released high levels of IL-1
and IFN gamma (high responder strains, such as C57Bl/6) were

c. albicans than

also noted to have lower tissue numbers of

did those strains of mice which released low levels of
cytokines (low responder strains, such as CJH).
oue to the relevance of cytokine release in the
differentiation and activation of microbicidal splenocytes,
Vecchiarelli et al. (1989) studied cytokine production in
the unprimed murine response to g. albicans.

Using hybrid

BALB/c x DBA/2 mice (two intermediate responder strains),
they evaluated the pattern and kinetics of selected cytokine
production in g. albicans infected animals.

GM-CSF, TNF

alpha, IFN gamma, and IL-1 were measured in the sera and
spleen cell supernates of infected mice.

High levels of GM-

CSF, TNF alpha, IFN gamma, and IL-1 were found six hours
after infection.
many days.

The high cytokine levels persisted for

A correlation existed between the ability of g.

albicans to induce anti-microbial protection in vivo and
cytokine production in vitro.

These data coupled with that

of Neta and Salvin (1983), suggest an involvement of
cytokines in the host protective response to g. albicans in
the mouse.
Further evidence for the involvement of cytokines in g.
albicans infection is demonstrated by g. albicans induction
of TNF production by human monocytes and LGLs in vitro (Djeu
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§:t Al· , 1988) .

TNF was detected as early as eight hours

after incubation with £. albicans.
occurred between 24 h and 48 h.
required.

Maximal levels of TNF

No priming signal was

Only partial inhibition of NK activity and TNF

induction was produced by the elimination of CD16+ (Fe
receptor) or NKHl+ in the LGL population.

Furthermore,

antibody and complement depletion of cells positive for Leu
1, a phenotypic marker of some NK cells, had little effect

on £. albicans induction of TNF by NK cells.

These data

suggest a population of LGL besides NK release TNF upon
stimulation with £. albicans.
TNF functions as an anti-tumor agent.

However, TNF is

primarily regarded as a key product of the mononuclear cell
response to microbial antigen involved in septic shock.

TNF

has long been known to activate phagocytic cells to enhance
anti-microbial activity and therefore may play a role in
microbial immunity (Philip and Epstein, 1986).

Djeu et al.

(1988) have postulated that TNF production is a normal
response of monocytes and LGL to stimulation by fungi such
as £. albicans.

Release of TNF assists in activation of PMN

and other effector functions to control £. albicans growth
(Djeu et al., 1988).

The effect of TNF resulting from£.

albicans infection on other effector populations has not
been studied.
The release of IFN gamma in response to £. albicans
infection is believed to activate macrophages and other
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cellular populations which when activated by these cytokines
acquire increased anti-fungal activity.

The inhibitory

activity of macrophages activated with IFN gamma is well
documented (Nathan et al., 1983).

Another result of IFN

gamma release may be activation of MHC-unrestricted
lymphocytes.

IFN gamma has previously been demonstrated to

produce a synergistic effect with low doses of IL-2 in the
activation of MHC-unrestricted lymphocytes (Limb et al.,
1989).

TNF also synergizes with low doses of IL-2 to induce

activation of lymphocytes with MHC-unrestricted cytotoxic
activity.

This activity requires the presence of IL-2 (Blay

et al., 1989).

Therefore, IFN gamma and TNF can cooperate

in the activation of lymphocytes to enhanced cytotoxic
activity.
Human IFN gamma directly inhibits g. albicans germ tube
formation (Kalo-Klein and Witkin, 1990).
unclear.

The mechanism is

However, the authors speculate that specific

receptors exist for IFN gamma and that the interaction of
IFN with the g. albicans yeast form inhibits CAMP production
and therefore hyphal formation (Kalo-Klein and Witkin,
1990).

By inhibiting yeast to hyphal transition, IFN gamma

may directly alter the pathogenic potential of g. albicans.
Besides host production of IFN gamma and TNF, an
essential part of the immune response to microbial infection
is the production and release of IL-2.

Ausiello et al.

(1988) exposed human PBMC in vitro to g. albicans and at
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dailY intervals the release of IFN gamma and IL-2 as well as
cytotoxicity for the tumor cell target, K562, was
determined.

They found that IFN gamma and IL-2 were

produced first, after which significant anti-K562
cytotoxicity was generated.

Although IFN gamma production

peaked prior to IL-2 production, the generation of cytotoxic
activity for the tumor target correlated with maximum IL-2
production following seven to ten days of culture.
Disturbances in the production of IL-2 and/or defective
responses to IL-2 may often be the cause of lowered immune
responsiveness {Gillis, 1983).

Dowjat et al. (1985)

demonstrated inter-strain differences in the proliferative
response of normal spleen cells to IL-2.

The differential

response appeared to be genetically determined by multiple
dominant or codominant genes.

The genetic determinants most

likely control differences in the composition of T
lymphocyte populations residing in the spleen, or in the
density of IL-2 receptors on splenocytes.

The proliferative

response of splenocytes from C57Bl/6 mice to IL-2 were among
the highest of the strains examined (high responding
strains), while C3H splenocytes possessed the lowest
response to IL-2 (low responder strains) (Dowjat et al.,
1985).

Differences in the kinetics of cytokine production

were noted between the two types of responders.

The

cytokine production of low responder strains peaked prior to
the cytokine production of high responder strains (Zhou et
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Al•i 1989b).

Furthermore, high responder spleen cells

contained two to four times more IL-2R transcript than low
responding strains and possessed a higher frequency of IL2R+ cells in the spleen (Zhou et al., 1989a).
It is interesting to note that the IL-2 highly
responsive strain, C57Bl/6 (Dowjat et al., 1985), was highly
resistant tog. albicans infections (Marquis et al., 1986).
The ability of this high responder strain to stimulate
higher levels of cytokine production for extended lengths of
time implies a possible role for this cytokine in the
differential anti-fungal response.

The increased levels of

IFN gamma, TNF and IL-2 suggest a higher potential for
activation of MHC-unrestricted populations.

This increase

may be responsible for the observed increase in survival
following g. albicans infection in high responder strains of
mice.

Cytokine Induction of MHC-Unrestricted Lymphocytes in
Response to

c.

albicans.

The cell wall of g. albicans is a powerful biological
agent, with a range of potential effects not dissimilar from
those induced in normal PBMC by IL-2 (Vecchiarelli et al.,
1989).

The microorganism is able to stimulate non-specific

lymphocyte proliferation both in vivo and in vitro (Ausiello
et al., 1989).

g. albicans possesses the ability to

initiate a cascade of events which allows generation of
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potent cytotoxic effectors that are active against tumor
cell targets in vitro and in vivo (Cassone et S!.l., 1987).
The activation of these lymphocytes is through lymphokine

c. albicans cell wall

production which is induced by the
(Ausiello et al., 1988).
Cassone et al., (1987)

found~.

albicans cell wall

components to induce anti-YAC-1 activity of peritoneal
effectors.

At least two cell wall fractions, the

glucomannan protein (GMP) and the insoluble glucan (GG),
induced the appearance of peritoneal immunoeffectors (55%
LGL cells, 30% macrophages, and 10% PMNs) which were similar
to those induced by the intact cells. The activity of the
cell wall fractions did not differ in the intensity of the
elicited effect, but rather in the kinetics of cytotoxicity
and its duration.

The cytotoxic potential generated by the

GMP was detected as early as the activity induced by intact
~.

albicans, but lasted a shorter period of time.

The

effector response of GG peaked later than the response to
intact

~.

albicans.

These findings indicate multiple

compounds within the cell wall of

~-

tumor activity with varying effects.
~.

albicans induce antiThe immune response to

albicans may be regulated by the breakdown products of

the cell wall either through immunological degradation or
release of cell wall components by

~.

albicans (Cassone et

al., 1987).
studies evaluating the induction of cell-mediated

24
cytotoxicity in cultured human PBMC by GMP, have shown GMP
induces a strong, LAK type, MHC-unrestricted cytotoxic
response, similar to that induced with IL-2 (Ausiello et
~.,

1989).

Analysis of surface phenotype coupled with

complement-mediated depletion experiments, indicated a
strong similarity between GMP and IL-2 activated cytotoxic
effectors.

Depletion of CD16+ (Fe receptor) and CDJ8+ (p45)

lymphocytes substantially decreased the cytotoxic activities
of the induced population against tumor targets (Ausiello et
al., 1989).
The above studies demonstrate that the cell wall of g.
albicans is a powerful antigen-complex which has the
capacity to serve as an immunomodulator.

The in vivo

relevance, if any, of g. albicans antigen induced activated
lymphocytes in immune surveillance against g. albicans,
tumors, or other microorganisms is presently unknown.

The

ability of the host to respond to infection with g. albicans
by producing lymphocytes with MHC-unrestricted cytotoxic
activity would indicate such a response is possible.

IL-2 Induction of MHC-Unrestricted Lymphocytes.
A. LAK cell phenomenon
IL-2 is a lymphokine produced by helper T cells that
stimulates the growth and differentiation of lymphocytes
(Herberman and Holden, 1978).

The incubation of normal

lymphoid cells with IL-2 leads to the generation of a MHC-

25

unrestricted cytotoxic lymphocyte population termed
iymphokine-activated killer (LAK) cells (Timonen et al.,
19 91).

several reports have shown that LAK cells are

effective in some patients with advanced cancer when
combined with IL-2 treatments (Richards, 1989).
A significant amount of literature has addressed the
functional capabilities of this cell population.

The term

LAK has been referred to as both an activity as well as a
cell population.

No agreement upon a defined function

associated with the term LAK has been reached.

Rather, any

function mediated by a lymphokine activated killer cell has
been described as LAK activity.
activity.

IL-2 is an inducer of LAK

However, the term lymphokine within lymphokine

activated killer cell indicates that any cellular product of
lymphocytes which induces this activity may result in LAK
activity.

Furthermore, the wide range of activities

mediated by this population may not be intrinsic to the
entire population.

It has therefore been argued that LAK

activity is a function of multiple cell populations rather
than a single cell population mediating several functional
activities (Reynolds and Ortaldo, 1987; Lotzova and
Herberman, 1987).

The precise relationship of these

multiple cell types or functional activities is unknown.

B. Characterization of LAK
Incubation of mouse spleen cells in vitro with IL-2
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results in the generation of a cell population capable of
lysing a wide variety of tumor cells.

IL-2 alone is fully

capable of generating LAK activity in the absence of other
added lymphokines (Yang et al., 1906).

Other cytokines

including TNF, IFN gamma and IL-4 also provide a degree of
activation for LAK activity which when coupled with low
levels of IL-2 provides a level of activity similar to that
obtained with high doses of IL-2 alone (Blay et al., 1990).
Lafreniere et al., (1986) have shown that IL-2
generated murine LAK cells stimulated in vitro remain
cytotoxic for 11 days.

However, the stimulated cells failed

to proliferate following the first cycle of expansion which
concluded at day 8.

Early studies of LAK phenotype in

C57Bl/6 mice demonstrated the expression of ASGM-1 and Thy1. 2 (Merluzzi et al., 1906; Merluzzi, 1985).

The majority

of splenic LAK effectors reside in the Thy-1+, Lyt-2+
population (Yang et al., 1986; Mule et al., 1987).

More

recent studies have demonstrated the effector phenotype of 9
day LAK cells to be Thy-1+, Lyt-2+, and ASGM-1+ cells. (Mule
et al., 1989).

Furthermore, it has been shown that 5-day

IL-2 induced effectors consist of two mutually exclusive
subsets bearing either the NK 1.1 or Lyt-2 phenotypic marker
(Kalland et al., 1987).

LAK Target Cell Recognition.
A model for LAK cell binding by a variety of cell
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surface proteins common to T cells and NK cells has been
proposed (Thiele and Lipsky, 1989).

Antibodies to

CDlS/CDlla (LFA-1), CD2 (LFA-2) and CD45 have all been shown
to interfere with LAK activity for tumor cells (Schmidt et
~.,

1985; Thiele and Lipsky, 1988).

It has also been noted

by a number of investigators that no single member of this
group of cell-surface proteins can be implicated in the
lysis of all susceptible targets by a given population of
effector cells (Thiele and Lipsky, 1989).

Thus, when LAK

cells have been examined, lysis of some susceptible targets
is not affected by binding of the same antibody to the same
effector cell population (Pawelec et al., 1985; Thiele and
Lipsky, 1988).

The variability with which anti-CD45, anti-

CD2 or anti-CD18 antibodies inhibit killing, and the
variability with which these agents interfere with
cytotoxicity, suggests that no unique cell surface receptor
is likely to explain the recognition and triggering of lysis
of all susceptible targets by a population of LAK effector
cells.

When multiple effector target cell combinations have

been examined, variation in inhibition of lysis of
antibodies to these cell surface proteins has been found to
be primarily dependent on the target cell employed.
Furthermore, an inverse relationship between the degree of
inhibition induced between antibodies to CD18/CDlla and
antibodies to CD2 has been noted.

Lysis of targets most

resistant to inhibition by anti-CD18/CD11a are relatively
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susceptible to inhibition by anti-CD2.

The inverse is also

true; target cells resistant to anti-CD2 inhibition are
susceptible to inhibition by anti-CD18/CD11a (Thiele and
Lipsky, 1988).

These experiments suggest that the

apparently promiscuous nature of target cell killing
exhibited by LAK cells appears related to the presence of
multiple sets of non-polymorphic receptor molecules which,
in varying combination, can interact with all or virtually
all, of a heterogeneous panel of tumor cell targets (Thiele
and Lipsky, 1989).
Evidence for the role of laminin-like molecules as
structures involved in tumor cell recognition by LAK was
provided by several findings.

First of all, the structure

is expressed only on lymphocytes mediating non-MHC
restricted cytotoxicity.

Secondly, affinity purified

antibodies to laminin block target cell killing.

Finally,

anti-laminin antibodies modulate the levels of IL-2 induced
proliferation of LAK (Schwarz and Hiserodt, 1988).

The

potential role of laminin-like molecules as receptors for
LAK in mediating anti-tumor activity was emphasized by
expression of a laminin matrix on tumor cells of mice, rats,
and humans but not on normal cells.

Therefore, the

interaction with laminin may serve as a mechanism for
recognition of cells that express altered growth or
differentiation properties.
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1§9hanisms of cytotoxic Activity for Tumor Cells.
Binding of tumor cell targets by effector cells is
required for cell mediated cytotoxicity.

The binding

process can occur through any of the complex mechanisms
previously discussed or through antibody-antigen mediated
contact.

Any process which brings these two cell

populations together possesses the potential to permit the
cytotoxic process.
The mechanisms of cytotoxicity can be separated into
distinct steps.

The first two are recognition and binding,

followed by the post binding cytotoxic effect which leads to
the lysis of the target cell.

A. Recognition
The recognition of the target cells by MHC-unrestricted
lymphocytes is unclear.
identified.

No singular receptor has been

It is presumed that LAK cells possess membrane

structures or receptors that mediate the recognition process
by which they distinguish targets (Edwards et al., 1989).
Recognition of tumor cells by non-antigen specific
lymphocytes has also been attributed to either recognition
of precise proteins or non-specific lectin like molecules
(Edwards et al., 1989).

Glycosylated proteins, glycolipids,

sialic acid, and amino sugars inhibit the interaction of
tumor cells and nonspecific effectors (Axberg, 1988; Yagita
et al., 1989).

Subtle molecular changes in surface exposed
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carbohydrates of target cells alter their sensitivity to
lysis by nonspecific effectors (Axberg, 1988).

Furthermore,

simple sugars such as mannose block the cytotoxic activity
of natural cytotoxic cells against solid tumors in vitro
(Stutman et al., 1980).

Several other possible target

molecules have been proposed to explain cell recognition
including transferrin (Alarcon and Fresno, 1985), laminin
(Hiserodt et al., 1985), fibrinogen {Schwarz and Hiserodt,
1988), and lectin-like recognition structures (Stutman et
al.

I

1980) •
As discussed in a previous section, antigen-independent

pathways of effector-target cell binding mediate the
interaction of CD2 on effector cells and LFA-3(CD58) on
target cells, LFA-1 (CD11a/CD18) on effector cells and ICAM1 (CD54) on target cells, and CD45 on effector cells (Thiele
and Lipsky, 1989).

The relative contribution of these

pathways to cell binding is variable among combinations of
effector and target cells.

Nitta et al., (1989) have

isolated another minor adhesive molecule on NK and LAK
cells, CD56.

However no definitive receptor has been

isolated and a combination of receptors may provide a
complex recognition scheme for these cells.

B. Binding
In order to exert their cytotoxic activity, cells must
bind the target, undergo an activation process leading to
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release of lytic factors and, finally, establish suitable
spatial conditions in order for these factors to reach the
target and to exert their function (Edwards et al., 1989).
Thus an intimate relationship between effector and target
cell is necessary.
Recent evidence suggests that the target cell may
participate actively in the mechanism leading to its own
lysis.

Results of the interaction between cells stimulated

with low levels of IL-2 and both NK-resistant and NKsensiti ve tumor targets have revealed slightly different
mechanisms of cytotoxicity.

LAK and K562 interactions were

characterized by a broad cell to cell contact whereas tumor
cell targets susceptible only to LAK cells did not undergo
extensive surface structure redistribution and the cell to
cell contact was established to a lesser extent.

Therefore,

it is conceivable that the susceptibility of the target cell
is also related to the ability of the target cell to
redistribute its surface structures, probably through a
rearrangement of cytoskeletal components.

These changes

might produce enhancement of the lytic effect by
establishing the appropriate micro-environment for cytotoxic
factors released by the effector cell (Arancia et al.,
1989).

c.

Cytotoxic granules
A current model postulates that stored cytotoxins in
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cytoplasmic granules are released onto target surf aces by
ca2+-dependent degranulation after appropriate stimulation
by the target cell (Hayes et al., 1989).

These granules can

be isolated from many killer cell types and contain, a poreforming cytotoxin called either perforin, cytolysin, or
pore-forming protein (Zanovello et al., 1989).

For example,

studies by Young (1989) have shown spleen cells cultured in
vitro in the presence of IL-2 and other T-cell growth
factors acquire perforin-containing granules (Young, 1989).
various molecules including TNF, serine esterases,
proteoglycans, and lysozymes have been isolated from
cytotoxic granules (Kamada et al., 1989).

The subcellular

location of the protease and serine esterase activity
appears to be in the outer cytoplasmic membrane and within
the intracellular granules (Lavie and Zucker-Franklin,
1989).

D. Release of granules
A simple and attractive model to explain lymphocyte
mediated killing has been proposed (Young, 1989).

Once the

effector cell is bound, the microtubule-organizing center
and the Golgi apparatus to which the granules are attached,
are repositioned to face the contact area with the target
cell {Zanovello et al., 1989).

This rearrangement serves to

direct the cytoplasmic granules toward the contact site and
to allow their content to be secreted by exocytosis into the
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narrow space between effector and target cell (Arancia et
§]..., 1989).

Upon release of the granules into the directed

space, perforin binds and polymerizes into cylinders with an
internal diameter of 160 A.

These cylinders orient in the

plane of the target cell membrane to form pores analogous to
the polymerized CS to C9 components of the membrane attack
complex of the complement system.

Pore formation leads to

rapid lysis.
An alternative model of cytotoxicity is the internal
disintegration model in which the LAK cell induces an
autolytic mechanism in the target.

This model, originally

proposed by Russell (1983), derives from the observation
that target cell DNA is released from the nucleus before
lysis and during the cytotoxic reaction.

The DNA of some,

but not all target cells undergoes fragmentation into repeat
units of 150-180 base pairs during attack.

Whether the

endonuclease activity is directly introduced from outside or
is endogenously activated from inside the target cell during
the lethal event is unknown.

Isolated granules have been

demonstrated to mediate target cell DNA release (Hayes et
al., 1989).

This activity is mediated by a serine protease

located in the secretory granules of the effector cell.
Proteolytic enzymes (proteases and serine esterases),
have long been implicated as having a major role in the
lytic phase of the cytotoxicity reaction (Lavie et !!l·
1985).

Besides a role in the release of DNA from target
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cells, proteases are involved in models of granule release.
A variety of such enzymes are distributed within different
compartments of the effector cell.

It is clear that all

enzymes involved in the cytotoxic response are not active at
all times during the cytotoxic response.

Furthermore, all

enzymes are not active against all target cells with which
they come in contact, rather a degree of selectivity exists.
complex cellular mechanisms triggered by the binding of the
target cell via the receptor are involved along with
proteolysis.

This may explain the selective nature of the

lysis which is not indiscriminately active against all
cells, but is dependent on target cell binding by the
specific receptor followed by triggering of a specific
cytotoxicity mechanism.

Therefore upon recognition of a

given target cell, any or all of several proteases which
induce the cytotoxic mechanism may be activated.

A model

has been suggested by which surf ace-associated proteolytic
enzymes that are concealed from the external environment
during the resting phase become exposed during cytolysis and
participate in the initial phase of target cell damage
(Lavie et al. 1985).
While protease inhibitors diminish cytotoxicity against
tumor cells, they are only active during the lytic process
(Lavie et al., 1985).

Chelating agents for ca+ 2 but not

Mg+ 2 , have been shown to block the exposure of the surface
proteolytic enzymes (Young et al., 1986).

Furthermore,
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conjugate formation is not inhibited by addition of protease
inhibitors.

It is believed that the activity of the

proteolytic enzymes occurs at a' stage which precedes the
calcium-dependent effector phase but which follows the
magnesium-dependent cell adhesion phase (Rodgers et al.
!988).

The accessibility of these proteolytic enzymes to

inhibition declines first to large molecular weight
inhibitors and within a few minutes to smaller molecular
weight inhibitors.

Following a ten minute incubation,

addition of protease inhibitors fails to inhibit the
cytotoxic response indicating the lytic process is completed
within a concealed and localized microenviroment.
Upon contact and recognition of a target cell, the
effector cell initiates a series of events by which
proteases, contained within granules, are brought to the
effector cell surface and released into the microenviroment.
This process mediates the cytotoxic activity of the effector
cell (Lavie et al. 1985; Hayes et al., 1989).

Relevance of Cytokine Activated Lymphocytes in

c.

albicans

infection.
The physiological role of cytokine activated
lymphocytes in Q. albicans infection is at present
uncertain.

This phenomenon may be an artifact of in vitro

activation protocols.

However, cells with MHC-unrestricted

cytotoxic activity have been shown to be present in fluids
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isolated from inflammatory sites (Goto and Zvaifler, 1985),
and at low frequency in the peripheral blood of normal
individuals (Lanier et al., 1987).

Therefore, the

possibility that cytokine activated lymphocytes play a role
in non-specific effector functions involved in host
resistance to neoplasia or various infectious diseases, must
be considered.

Cytokine activated lymphocytes may possess

relevant anti-g. albicans activity during the immune
response.

g. albicans possesses the ability to increase

cytokine production in the host.

The cytokines which are

produced in response to g. albicans have been shown to
activate MHC-unrestricted, cytotoxic lymphocytes
(Vecchiarelli et al., 1989).

Furthermore, MHC-unrestricted

cytotoxic lymphocytes can be isolated from mice either
inoculated with g. albicans or its cell wall constituents
(Cassone et al., 1987; Ausiello et al., 1988).

It is

unfortunate that these investigations failed to evaluate the
anti-g. albicans activity of these cellular populations.
This dissertation will evaluate rIL-2 activated,
lymphocyte-mediated, anti-g. albicans growth inhibitory
activity, in vitro.
The major objectives of this investigation were: 1) to
determine whether such a population can be activated to
mediate anti-g. albicans activity, 2) to characterize the
cell population through phenotyping and functional activity,
and 3) to provide a basis for assessment of IL-2 activated
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iymphocytes as a protective
population.

anti-~.

albicans effector

MATERIALS AND METHODS

C57Bl/6 female mice, ages 6 to 7 weeks, were obtained
from Jackson Laboratory, Bar Harbor, ME.

Experimental mice

were 6 to 12 weeks of age when used in experiments.

Tumor Cell Lines
The cell line P815, a methylcholanthrene-induced
mastocytoma in DBA/2 mice (Plaut et al., 1973) was obtained
from the American Type Culture Collection (ATCC-TIB-64),
Rockville, MD.

YAC-1, a Moloney virus-induced lymphoma in

A/Sn mice (Sjogren and Marbrook, 1965) was obtained from Dr.
J. Clancy, Loyola University Medical Center, Maywood, IL.

These tumor cell lines were used for assessment of tumor
cytotoxic activity.

Cells were maintained in suspension

cultures in vitro in Corning 25 cm2 tissue culture flasks
(Corning Glass Works, Corning, NY) in RPMI 1640 (Gibco
Laboratories, Grand Island, NY) supplemented with 10% fetal
bovine serum (FBS; low LPS; Gibco Laboratories), 100
units/ml penicillin, 100 µg/ml streptomycin (Whittaker M. A.
Bioproducts, Walkersville, MD), 0.1 mM non-essential amino
acids and 2 mM 1-glutamine (Gibco Laboratories, Grand
38
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Island, NY).

This medium was used throughout, except where

noted, and referred to as culture medium.

Eungal culture
candida albicans

American Type Culture Collection

(ATCC) 58716, was obtained from Or. T. Hashimoto, Loyola
university Medical Center, Maywood, IL, and used throughout
this investigation.

Cultures were stored at 25°C on

sabouraud's dextrose agar (SDA) (Becton Dickinson and Co.,
cockeysville, MD) •

Cells used for experimentation were

cultured overnight at 37°C on SDA, collected as isolated
colonies, and washed once in Hank's balanced salts solution
(HBSS).

Cultures of yeast form with greater than 15%

budding g. albicans were discarded.

g. albicans were

inoculated into RPM! 1640 medium prepared as described above
except supplemented with 1% FBS not 10% FBS.
referred to as assay medium.

~.

This medium is

albicans hyphal forms were

obtained by incubation at 37°C in assay medium.

Inoculum of

l x 10 5 yeast cells/ml yielded approximately 100% hyphal
fragments ranging in length from 30-50 µm when incubated for
2 h at 37°C.

Recombinant IL-2
Purified recombinant human IL-2 was obtained from
Hoffmann LaRoche, Inc., Nutley, NJ.

The recombinant IL-2

(rIL-2) was diluted to desired concentrations in culture
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medium.

_erotease Inhibitors
TAME (p-a-toluenesulfonyl-L-arginine methyl ester or
Na-p-tosyl-L-arginine), aprotinin (trasylol), and PMSF
(phenylmethylsulfonylfuloride or p-a-toulenesulfonyl
fluoride) were purchased from Sigma Chemical Co. (St. Louis,
MO).

TAME, a serine protease inhibitor, specific for

arginine binding sites, was diluted to a final experimental
concentration of lOµM.

Aprotinin, a trypsin inhibitor, was

used at a final experimental concentration of 10% of the
initial commercial solution, and PMSF, a serine esterase
inhibitor, was dissolved in ethyl alcohol prior to final
experimental concentration of 300 µg/ml in RPMI 1640.
Addition of these reagents to target cells showed no
alteration in [ 3H] uridine uptake by these cells compared to
untreated

~.

albicans.

The reagents did not affect effector

cell viability as judged by trypan blue exclusion.

IL-2 Activation of Lymphocytes
Spleens from untreated mice were aseptically removed.
Single cell suspensions were prepared by dissociating the
spleen through a 60-gauge wire mesh with the hub of a
syringe.

Spleen cells were washed once in HBSS prior to

placement in culture medium containing 5 X

10~

M 2-

mercaptoethanol (2-ME) at a concentration of 2.5 x 10 6
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cells/ml with 1500 U/ml rIL-2 in Falcon, Multiwell plates
(Becton Dickinson and Co., Oxnard, CA).

The cells were

harvested following incubation at 37°C, overlaid onto
Lymphocyte Separation Medium (Litton Bionetics, Kensington,
MD) and centrifuged at 1000 X g for 20 min.

The cells at

the interface were washed twice with HBSS prior to
assessment of cytocidal or growth inhibitory activity.

Percoll Separations
Freshly isolated splenocytes, harvested as above, were
subjected to discontinuous Percoll gradients consisting of
50 to 70% Percoll (Sigma Chemical, St. Louis, MO) at 1500 x
g for 30 min.

Each cell fraction was collected, washed

twice in HBSS and resuspended in assay media prior to
experimentation.

Day 7 cell fractions were designated as

fraction 1, representing the population banding above the
50% gradient; fraction 2, representing the population
banding between the 50% and the 60% gradient; and fraction
3, representing the population banding below the 60%
gradient.

Supernate Collection
Day 7 cultured cells were harvested by centrifugation,
and separated from culture medium.

Following separation,

culture media from normal cells as well as from those cocultured

with~.

albicans at 25:1 effector : target ratios
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were concentrated 75 fold with a Diaflo ultrafiltration
membrane (Amicon Corp., Danvers, MA) concentration device
with a UMlO filter.

12 to 200 µl of concentrated supernate

were analyzed for inhibitory and cytotoxic activity.

preparation of Cell Sonicates
Effector populations were resuspended in polypropelene
12 x 75 mm tubes at 5 x 10 6 cells/ml in 1 ml.

Populations

were subjected to sonication by the Fisher Sonic
oismembrator Model 300 (Farmingdale, NY) at 35% capacity for
15 seconds while on ice.

Sonicated cells were < 1% viable

as judged by trypan blue exclusion.

Preparations of

sonicates including membranes and cytosols were treated as
equivalent cell populations at 5 x 106 /ml for analysis of
inhibitory or cytotoxic activity.

Kinetic Analysis of Cell Recovery and Proliferation
Freshly isolated spleen cells (collected as above) were
cultured in culture media and harvested (as above)
sequentially from day 1 to day 9 of culture.

The total

number of recoverable cells divided by the original number
of cells placed in culture, multiplied by 100 was the
percent recovery.

Lymphoid cells were plated in 96 well

flat-bottomed microtiter plates (Corning 25861, Corning, NY)
at 5 x 10 5 cells/well.

Cells were cultured with or without
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300 u/well of rIL-2. Cells were cultured from 1 to 9 days
after which they were pulsed with 1 µCi/well of [ 3H]
thymidine (ICN Radiochemicals, Irvine, CA).

After 6 h of

incubation, cells were harvested on the PhD harvester
(Cambridge Technology, Cambridge, MA) and associate
radioactivity determined with a Beckman LS5801
scintillation counter (Irving, CA).

~

liquid

Proliferation was

defined as the incorporation of [ 3H] thymidine in the
experimental wells containing rIL-2 (300 U/ml) divided by
the incorporation of [ 3H] thymidine in the control wells
without rIL-2.

Flow cytometric Analysis
Antibodies used to analyze the phenotype of cell
populations included monoclonal rat anti-mouse Lyt 2.2
(clone 53-6.7; biotin conjugated), monoclonal rat anti-mouse
Thy 1.2 (clone 30Hl2; biotin-conjugated) and monoclonal rat
anti-mouse L3T4 (clone GK 1.5; phycoerythrin-conjugated),
all from Becton-Dickinson (Mountain View, CA).

Monoclonal

anti-NK 1.1 (clone PK136; mouse IgG) was obtained from ATCC
(Rockville, MD).

Rabbit anti-Asialo GM-1 (ASGM-1) was

obtained from Wako Chemicals USA, Inc. (Dallas, TX), and was
used with goat anti-rabbit Ig fluorescein conjugate
(Boehringer Mannheim Biochemicals; Indianapolis, IN).
Fluorescein conjugated goat anti-mouse IgG from Zymed
Laboratories Inc. (South San Francisco, CA) was utilized to
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detect surface IgG.

Streptavidin-phycoerythrin was obtained

from vector Laboratories (Burlingame, CA).

Effector

populations were prepared for phenotyping by washing 1.5 x
106 cells per sample once with cold phosphate buffered
saline (PBS).

The cells were incubated with the primary

antibody for 30 min. on ice.

Following two washes in cold

PBS, the cells were incubated for an additional 30 min. on
ice with secondary antibody, protected from light.

Control

samples consisted of cells incubated only with the secondary
antibodies.

The cells were washed twice in cold PBS, and

then fixed with 0.1 ml of 1% paraformaldehyde in saline and
stored at 4°C.

The samples were washed twice and

resuspended in PBS prior to flow cytometric analysis (FACS
Analyzer ISA, Becton-Dickenson, Mountain View, CA).

Complement-Mediated Depletion Analysis
Antibodies used to deplete cell populations included
monoclonal anti-Lyt 2.2 (clone AD4(15); mouse IgM) from
Accurate Chemical and Scientific Corp. (Westbury, NY), antiThy-1 from Hybritech Inc. (San Diego, CA), monoclonal antiNK 1.1 (clone PK136; mouse IgG) obtained from ATCC
(Rockville, MD), and rabbit anti-ASGM-1 obtained from Wako
Chemicals USA, Inc. (Dallas, TX).

Viable lymphoid cells

were obtained with a Lymphocyte Separation Medium gradient
as above and washed twice with HBSS.

Effector populations

were depleted of cells bearing specific antibodies by
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incubating 1 x 107 cells with saturating levels of antibody
for 1 h at 4°C.

The cells were washed 3 times with HBSS

with 1% FBS to remove excess antibody and then 100 µl of Low
ToX M rabbit complement (Accurate Chemical and Scientific
corp., Westbury, NY) was added to the cell pellet.
Following a 1 h of incubation at 37°C, cells were washed,
obtained with a Lymphocyte Separation Medium gradient as
above, and washed twice prior to assessment of inhibitory or
cytotoxic activity.

Effectiveness of the depletion was

assessed by flow cytometric analysis and number of recovered
cells from treated populations compared to untreated
populations.

Immunomagnetic selection
Antibodies used for immunomagnetic selection included
monoclonal anti-Lyt 2.2 (clone 19/178; mouse IgG) obtained
from Dr. Erlich Hammerling, Sloan-Kettering Institute New
York, NY, monoclonal anti-NK 1.1 (clone PK136; mouse IgG)
obtained from ATCC (Rockville, MD), and magnetic goat antimouse IgG obtained from Advanced Magnetics (Cambridge, MA).
Viable lymphoid cells were obtained with a Lymphocyte
Separation Medium as above and washed twice with HBSS.

1 x

107 day 7 cells were treated with saturating levels of
antibody for 1 h at 4°C.

The cells were washed 3 times with

HBSS with 1% FBS to remove excess antibody and then 1 ml of
magnetic antibody was added to the cell pellet.

Following 1
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h of incubation at 4°C, antibody sensitized populations were
removed with a magnet.

Separated populations were activated

with 1500 U/ml rIL-2 18 h at 37°C, 5% C02 • Effector
populations were washed, centrifuged over a Lymphocyte
separation Medium gradient as above, and washed twice prior
to assessment of inhibitory or cytotoxic activity.

Tumor Cell Cytotoxicity Assay
Tumor cells maintained in vitro were washed once in
culture medium, pelleted by centrifugation at 500 x g for 10
min and resuspended in approximately 0.1 ml of culture
medium.

100 µCi of [ 51 Cr] chromate (New England Nuclear,

Boston, MA) was added to 1 x 107 cells in a final volume of
0.2 ml.

The cells were incubated at 37°C with 5%

with agitation every 10 min.

co2 for 1 h

The cells were washed 4 times

in HBSS, resuspended to 5 x 105 cells/ml in culture medium
and 0.01 ml (5 x 103 cells) were aliquoted to each well of a
96 well, round bottom assay plate (Corning Glass Works,
Corning, NY).

Radiolabelled YAC-1 or P815 cells were

cultured for 4 h with lymphoid cells.

Following 4 h of

incubation, the supernates were removed using a Skatron
harvesting press (Skatron Inc., Sterling, VA) and associated
radioactivity determined with a 4/600 ME PLUS automatic
gamma counter.

Maximum release of radioactivity was

obtained by adding 0.05% Nonident P-40 (Sigma Chemical
Co., St. Louis, MO).

Results are expressed as%
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cytotoxicity as calculated by the formula: % cytotoxicity =
{[(experimental DPM) - (minimum DPM)] / ((maximum DPM) - (
minimum DPM)]} x 100.

All experimental means were

calculated from triplicate values.

Lytic units (LU), were

calculated by the method of Pross et al. (1981), and
represent the number of effector cells per 1 x 107 effectors
required to achieve 20% lysis of the target.

Lytic units

were calculated by a program written by David Coggins (NCI,
Fredrick, MD).

c.

albicans Inhibition
Fungal cells used for experimentation were collected

from isolated, overnight SDA colonies, and washed once in
HBSS.

Yeast form cells were resuspended to 2 x 10 5

assay media.

/

ml in

1 x 104 cells were then added to individual

wells of 96 well plates (Corning 25861, corning, NY).

g.

albicans hyphal forms were obtained by incubation at 37°C in
5% C02 for 2 h.

Various numbers of effector cells were

added at ratios of 50:1 to 6:1.

After 3 h incubation at

37°C in 5% co2 , effector cells were lysed and removed by
washing with water using a PhD cell harvester (Cambridge
Technology, Cambridge, MA).

0.05 ml of RPMI 1640 with 1%

FBS and 1 µCi per well of [ 3H] uridine (ICN Radiochemicals,
Irvine, CA) was added to individual wells.

Following 1 h

incubation at 37°C, 5%C02 , 25 U lyticase (Sigma Chemical, St.
Louis, MO) in 50 µl HBSS was added to individual wells for
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• h at 25°C.
0 5

Cells were then harvested with a PhD

harvester and associated radioactivity etermined with a
seckman LS5801
Inhibition

of~.

(DPM (effector
~·

~

liquid scintillation counter.
albicans = {[(DPM

and~.

~.

Growth

albicans control) -

albicans - effector control))] /

glbicans control]} x 100.

[DPM

All cultures were prepared at

least in triplicate and the mean inhibition of those values
determined.

Inhibitory units (IU), a modification of the

lytic unit method of Pross et al.

(1981), were calculated as

the number of effector cells per 1 x 107 effectors required
to achieve 20% inhibition of the target.
were calculated as DPM

~.

Inhibitory units

albicans alone - DPM experimental

sample = inhibited counts.

Inhibited counts were determined

by a modification of a program written by David Coggins
(NCI, Frederick, MD) and presented as inhibitory units.

Cold target Inhibition
Tumor cytotoxicity and

~.

albicans inhibitory assays

were conducted at 40:1 effector : target ratio.
Additionally, cultured tumor targets (P815 and YAC-1) and
heat inactivated (5 minutes at 100°C)
were utilized as cold targets.

~-

albicans hyphae

Cold target inhibitors were

washed twice in HBSS prior to co-incubation with effector
and target cells at concentrations from 1 x 104 to 5 x 10 6
additional cold targets per well.

Naive thymocytes were

utilized as unrelated control cell populations.

Thymocytes
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were added to each well such that the final concentration of
cold targets and thymocytes of each well totalled 5 x 106
cells per well.

Tumor culture supernates were collected

both from overnight and 3 day tissue culture flasks as well
as from cultures of 5 x 10 6 cells in 0.1 ml from a 96 well
plate following a 4 h culture period.

~-

albicans

supernates were collected following heat inactivation.

The

supernates were assessed for inhibition of cytotoxicity and
~·

albicans inhibition.

statistics
Comparisons of mean LU and IU values were performed
using the t test for small-samples concerning difference
between two means (Freund, 1979).

RESULTS

A,9tivation of Anti-fungal and Anti-tumor Activity of
splenocytes with rIL-2
A. Anti-fungal and anti-tumor activity of splenocytes
The purpose of initial experiments was to determine the
inherent anti-fungal and anti-tumor activity of murine
splenocytes.

Splenocytes possessed no growth inhibitory

activity against

~.

albicans as judged by inhibition of [ 3H]

uridine uptake (Figure lA).

Neither was there activity

against the NK-resistant cell line, P815, as judged by [ 51 Cr]
release (Figure lC).

Low levels of activity were observed

for the NK sensitive target, YAC-1, as judged by [ 51 Cr]
release (Figure lB).

This activity could be enriched by

discontinuous Percoll density gradient selection.
Splenocytes from interface

1

(cells which did not enter a

50% concentration of Percell) showed enhanced activity
against the YAC-1 tumor cell line when compared to
unfractionated splenocytes (p<0.05) (Figure 2B).
Unfractionated splenocytes possessed 5.2% large granular
lymphocytes compared to splenocytes from interface

1

which

possessed 38.3% large granular lymphocytes as judged by
Wright-Geimsa staining of cytospin preparations.
50

No
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Figure 1.

c. albicans growth inhibition and tumor cell cytotoxicity of
day o splenocytes. A. ~. albicans growth inhibition was
assessed by the incorporation of [ 3H] uridine. Data are
presented as % inhibition and inhibitory units per 107 cells
at 20% inhibition (IU). B. YAC-1 cytotoxicity is expressed
as % cytotoxicity as judged by [ 51 Cr] release and by lytic
units per 10 7 cells at 20% cytotoxicity (LU). c. P815
cr.totoxicity is expressed as % cytotoxicity as judged by
7
[ 1Cr] release and by lytic units per 10 cells at 20%
cytotoxicity (LU). Data are expressed as the mean± s. D.
for 3 independent experiments.
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Figure 2.

c. albicans growth inhibition and tumor cell cytotoxicity of
percoll fractionated day o splenocytes. Day O splenocytes
were fractionated by discontinuous percoll density gradient
separation. Cells from each interface were harvested and
washed: Fraction 1, 50% gradient (Fract. 1); fraction 2, 60%
gradient (Fract. 2); and fraction 3, 70% gradient (Fract.
3). A. g. albicans growth inhibition was assessed by the
incorporation of [ 3H] uridine. Data are presented as %
inhibition and inhibitory units per 107 cells at 20% inhibition (IU). B. YAC-1 cytotoxicity is expressed as%
cytotoxicity as judged by [ 51 Cr] release and by lytic units
per 107 cells at 20% cytotoxicity (LU). c. P815
cxtotoxicity is expressed as % cytotoxicity as judged by
7
1
[ Cr] release and by lytic units per 10
cells at 20%
cytotoxicity (LU). *,
(p<0.05) Significant difference
between fraction 1 activity and unfractionated splenocyte
activity. Non-significant comparisons are not labelled, all
significant comparisons are labelled. Data are expressed as
the mean ± s. D. for 3 independent experiments.
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increase in anti-YAC-1 tumor cell activity was noted for the
other Percell separated splenocytes.

No enrichment of

activity was noted for any of the other Percell separated
cell populations against either g. albicans (Figure 2A) or
P815 (Figure 2C) .
These data demonstrate no anti-g. albicans or anti-P815
activity in either splenocytes or Percell separated
populations at the effector to target ratios used in these
experiments.

The anti-YAC-1 activity of normal splenocytes

was enhanced in low density Percell fractions, suggesting
that resident splenic NK do not mediate anti-g. albicans
activity.

B. Activation of anti-fungal and anti-tumor activity in
splenocytes with rIL-2
Previous studies have shown that activation of lymph
node cells by rIL-2 augments their anti-fungal activity
(Beno and Mathews, 1990) and anti-tumor activity (Herberman
and Holden, 1978).

To evaluate the effect of this cytokine

on splenocytes, such cell populations were activated with
rIL-2 and assayed for their capacity to mediate anti-g.
albicans and anti-tumor activities (Figure 3).
Following 1 day activation by rIL-2, no increase in
either g. albicans growth inhibition (Figure 3A) or antiP815 cytotoxic activity (Figure JC) was noted for these
splenocytes when compared to the activity of day o
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splenocytes or splenocytes cultured for 1 day without rIL-2
(unactivated) (p>0.05).

However, the increase in anti-YAC-1

cytotoxic activity (Figure JB) was significant when compared
to day o splenocytes or unactivated day 1 splenocytes
(p<0.05).

Following 3 days activation with rIL-2,

c.

albicans growth inhibition (Figure 4A) was increased
significantly when compared to day o splenocyte activity or
the activity of splenocytes cultured for 3 days without rIL2 (unactivated day 3) (p<0.05).

Anti-P815 cytotoxic

activity of splenocytes (Figure 4C) was increased
significantly at day 3 of culture (p<0.05).

Splenocytes

cultured without rIL-2 showed no (p>0.05) anti-P815
activity.

Anti-YAC-1 activity (Figure 4B) was enhanced

significantly from day O to day 3 of incubation with rIL-2
(p<0.05).

No change in anti-YAC-1 activity was observed for

splenocytes cultured 3 days without rIL-2 (p>0.05) when
compared to day O splenocytes.
rIL-2 for 7 days,

~.

Following activation with

albicans growth inhibition and anti-

tumor cytotoxic activity was increased significantly over
day o splenocytes (p<0.05)

(Figure 5).

No cells were

recovered from splenocytes cultured without rIL-2 for more
than 3 days.

The

~.

albicans growth inhibitory activity of

splenocytes cultured for 7 days with rIL-2 was increased
significantly (p<0.05) when compared to 3 day activated
splenocyte populations for all targets examined (Figures 4
and 5).

Day O splenocyte activity against all targets
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Figure 3.

c. albicans growth inhibition and tumor cell cytotoxicity of
day 1 rIL-2 activated populations. A. ~. albicans growth
inhibition was assessed by the incorporation of [ 3H]
uridine. Data are presented as % inhibition and inhibitory
units per 107 cells at 20% inhibition (IU). B. YAC-1
critotoxicity is expressed as % cytotoxicity as judged by
7
1
[ Cr] release and by lytic units per 10
cells at 20%
cytotoxicity (LU). c. P815 cytotoxicity is expressed as%
cytotoxicity as judged by [ 51 Cr] release and by lytic units
per 10 7 cells at 20% cytotoxicity (LU). *, (p<0.05)
Significant difference between activity of day 1 rIL-2
activated population compared to day o splenocyte activity.
**, (p<0.05) Significant difference between activity of day
1 rIL-2 activated populations compared to the activity of
day 1 cultured without rIL-2. Data are expressed as the
mean ± s. D. for 4 individual experiments.
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Figure 4.
c. albicans growth inhibition and tumor cell cytotoxicity of
day 3 rIL-2 activated populations. A. ~. albicans growth
inhibition was assessed by the incorporation of [ 3H]
uridine. Data are presented as % inhibition and inhibitory
units per 107 cells at 20% inhibition (IU). B. YAC-1
critotoxicity is expressed as % cytotoxicity as judged by
7
[ 1cr] release and by lytic units per 10
cells at 20%
cytotoxicity (LU). C. P815 cytotoxicity is expressed as%
cytotoxicity as judged by [ 51 Cr] release and by lytic units
per 107 cells at 20% cytotoxicity (LU).
*, (p<0.05)
Significant difference between activity of day 3 rIL-2 activated population compared to day o splenocyte activity.
**, (p<0.05) significant difference between activity of
either day 3 rIL-2 activated populations compared to the
activity of day 3 splenocytes cultured without rIL-2. Data
are expressed as the mean + s. D. for 4 individual experiments.
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Figure 5.
albicans growth inhibition and tumor cell cytotoxicity of
day 7 rIL-2 activated populations. A. ~. albicans growth
inhibition was assessed by the incorporation of [ 3H]
uridine. Data are presented as % inhibition and inhibitory
units per 107 cells at 20% inhibition (IU). B. YAC-1
critotoxicity is expressed as % cytotoxicity as judged by
7
1
[ Cr] release and by lytic units per 10
cells at 20%
cytotoxicity (LU). c. P815 cytotoxicity is expressed as%
cytotoxicity as judged by [ 51 Cr] release and by lytic units
per 107 cells at 20% cytotoxicity (LU). *, (p<0.05)
Significant difference between activity of day 7 rIL-2 activated population compared to day o splenocyte activity.
Data are expressed as the mean ± s. D. for 4 individual
experiments.
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displayed in Figures 3, 4, and 5 are taken from Figure 1 and
used to demonstrate comparative activities.

The activity of

daY o splenocytes was compared twice in parallel with the
previous studies of rIL-2 activated lymphocytes at days 1,
3, and 7.

No differences in activity were observed between

these cell populations and the day o splenocytes presented
above.
These data demonstrate a concurrent increase over time
in anti-fungal and anti-tumor activities when splenocytes
were cultured with rIL-2 at days 1, 3, and 7.

Furthermore,

despite the presence of enhanced NK activity at day 1, no
anti-fungal activity was observed suggesting NK do not
mediate anti-g. albicans activity.

The induction of anti-

P815 activity at days 3 and 7 does correllate with the
ability of the population to mediate anti-g. albicans
activity.

These results suggest activation to P815 tumor

cytotoxic activity is associated with cell population
activation to anti-fungal activity.

c. Kinetic analysis of lymphoproliferation, cell recovery,
anti-fungal activity, and anti-tumor activity of
splenocytes following activation with rIL-2.
To establish the time course for maximal functional
activity as well as maximal cell recovery, splenocyte
populations were analyzed for anti-tumor lytic activity,
anti-g. albicans growth inhibitory activity, cell recovery,
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and lymphoproliferation during 9 consecutive days of
activation with rIL-2 (1500 U/ml).
In separate experiments from those described in Figures
l-5, splenocytes acquired anti-tumor activity against both
YAC-1 and P815 cell lines with peak activity occurring at
day 7 of culture with 1500 U/ml rIL-2 (Figure 6).

A

significant increase in anti-YAC-1 activity was noted as
early as day 1 when compared to day O splenocytes (p<0.05).
Anti-P815 activity was not significantly increased over the
day O splenocyte population until day 3 in culture and
demonstrated peak activity at day 7 (p<0.05).

~.

albicans

growth inhibition peaked at day 7 of culture with
significant growth inhibition appearing by day 3 when
compared to the activity of day o splenocytes (p<0.05).

The

activity against all targets increased until day 7 at which
time the activity against all targets declined numerically,
but not significantly from day 7 (p>0.05) (Figure 6).
Maximal cell recovery coincided with maximal anti-fungal
activity, on day 7 (Figures 6 and 7).

Maximal proliferation

of splenocytes was on day 4 of activation, 3 days prior to
maximal cell recovery (Figure 7).

Splenocytes cultured

without rIL-2 showed no proliferative capacity and cell
viability decreased from 75.3%
9.2% by day 3 of culture.

±

8.0% at day 1 to 8.8% +

Without rIL-2 no viable

lymphocytes were recoverable after 3 days in culture.
These data expand on previous experiments within this
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Figure 6.
Kinetic analysis of anti-tumor and anti-~. albicans activity
of splenocyte populations activated with rIL-2. Splenocyte
populations were cultured for O to 9 days with 1500 U/ml
rIL-2 and assessed at daily intervals for anti-tumor
activity against YAC-1 and P815 and anti-~. albicans
inhibitory activity. ~· albicans growth inhibition was
assessed by the incorporation of [ 3H] uridine. Data are
presented as inhibitory units per 10 7 cells at 20%
inhibition (IU). YAC-1 and P815 cytotoxicity is expressed
as lytic units per 10 7 cells at 20% cytotoxicity (LU) as
judged by [ 51 Cr] release. Data are expressed as the mean ±
s. D. for 3 independent experiments.
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Figure 7.
Kinetics of proliferation and cell recovery from cultures of
rIL-2 activated populations. Splenocyte populations were
assessed for proliferation following culture with 1500 U/ml
rIL-2 at the days indicated. The percent of recovered cells
during the activation with rIL-2 is also expressed. Data
are expressed as the mean ± s. o. for 3 independent experiments.
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study to demonstrate maximal anti-tumor activity, antifungal activity, and cell recoverability occur at day 7 of
culture with rIL-2.

Due to these observations, the day 7

rIL-2 activated population was selected for further
characterization.

susceptibility of Various Strains of Candida to rIL-2
activated population
To examine if the anti-fungal effect of the splenocyte
population was limited to Q. albicans strain (ATCC #58716)
utilized in this study, various clinical isolates of Q.
albicans and species of Candida were evaluated for their
susceptibility to this form of lymphocyte mediated growth
inhibition.
Figure 8 depicts the growth inhibitory effect of the
rIL-2 activated population on various clinical isolates of
Candida albicans, Candida tropicalis, Candida parapsilosis,
or Torulopsis glabrata.

All isolates of Q. albicans and

species of Candida evaluated were susceptible to growth
inhibition by rIL-2 activated populations, indicating the
anti-Q. albicans activity observed by the rIL-2 activated
population is not limited to the strain of Q. albicans
utilized in this study.

Characterization of rIL-2 Activated Populations
A. Flow cytometric analysis of rIL-2 activated populations
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Figure 8.
Growth inhibition of rIL-2 activated populations for various
Candida strains and species. rIL-2 activated populations
were assessed for g. albicans growth inhibition against
clinically isolated strains of g. albicans by the uridine
method and presented as % inhibition and IU.
rIL-2
activated populations were also assessed for growth
inhibition against clinically isolated species of Candida.
g. albicans and Candida species growth inhibition was
assessed by the incorporation of [ 3H] uridine and data
presented as % inhibition and inhibitory units per 107 cells
at 20% inhibition (IU).
*, indicates ATCC 58716 strain of
g. albicans utilized throughout study. Data are expressed
as the mean ± S. D. for 3 independent experiments.
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In order to determine the phenotypic nature of rIL-2
activated populations and that of day O splenocytes, both
populations were assessed for the expression of the
phenotypic markers; ASGM-1, NK 1.1, Ig, Thy-1.2, L3T4, and
Lyt-2.2.
Four experiments comparing phenotypic expression of day
0 splenocytes to rIL-2 activated populations are summarized
in Table I.

52.7 ± 7.6% of day

1.2 and 40.9

±

o

splenocytes expressed Thy-

4.3% expressed ASGM-1.

19.7

±

3.3% of the

day O splenocyte population expressed the Lyt-2.2 T cell
marker while 10.7 ± 2.7% expressed the NK 1.1 marker.

The

number of rIL-2 activated cells expressing Thy-1.2 increased
to 92.0

±

3.8% and while the number of rIL-2 activated cells

expressing ASGM-1 increased to 85.7
culture with rIL-2.

53.3

±

±

9.6% after 7 days in

8.3% of the rIL-2 activated

population expressed the Lyt-2.2 T cell marker while 36.8 +
6.1% expressed the NK 1.1 marker.

The presence of Ig and

L3T4 phenotypic markers were also examined for rIL-2
activated populations and day

o

splenocytes.

Expression of

both phenotypic markers decreased during time in culture.
Ig expression decreased from 48.7 + 6.3 to 4.3 ± 3.7% and
L3T4 expression decreased from 30.1 ± 4.0 to 6.0% ± 3.2%.
These data indicate that following 7 days activation
with rIL-2, a high percentage of lymphocytes express the
markers Thy-1.2 and ASGM-1 while the percentage of cells
expressing the markers NK 1.1 and Lyt-2.2 is intermediate

73

Table I. Surface phenotype of day O splenocytes or day 7
rIL-2 activated population.
Phenotypic
Marker

Day 0
% Expressing8

Thy-1.2

52.7 + 7. 6b

L3T4

30.1 + 4.0

LYT-2.2

19.7

ASGM-1

92.0

±

3.8

6.0 + 3.2

3.3

53.3

40.9

±
±

4.3

85.7 + 9.6

NK 1.1

10.7

±

2.7

36.8 + 6.1

Ig

48.7

±

6.3

4.3

±

±

8.3

3.7

FITC-RAMigc

7.8 + 2.2

8.5 + 3.7

PE-avidind

8.9 + 3.1

8.7

FITC-GAMige

6.3 + 4.4

4.6 + 3.1

As judged
b Mean + s.
c Secondary
d Secondary
e Secondary
a

Day 7
% Expressing

by flow cytometric immunofluorescence.
D. of 4 independent experiments.
antibody for ASGM-1 (rabbit Ig).
marker for Thy-1.2, Lyt-2.2.
antibody for NK 1.1 (goat Ig).

±

4.2
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~ithin

the population.

B. Phenotypic expression of NK 1.1 and Lyt-2.2
To determine whether the phenotypic markers Lyt-2.2 and
NK 1.1 are expressed on the same population with the rIL-2
activated population, antibody and complement depletion
experiments were performed, followed by flow cytometric
analysis.
Flow cytometric analysis of rIL-2 activated populations
treated with anti-Lyt-2.2 and complement show a decrease in
cells staining for Lyt-2.2 from 48% to 13% (Figure 9) in a
representative experiment.

In contrast, the rIL-2 activated

population treated with anti-Lyt-2.2 and complement
displayed increased expression of NK 1.1 from 35% to 59%.
The rIL-2 activated population treated with anti-NK 1.1 and
complement showed a decrease in cells staining for
expression of NK 1.1 (35% expression in untreated
populations compared to 11% expression of NK 1.1 in treated
populations) yet displayed an increase in expression of Lyt2. 2 from 48% to 59%.

Evaluation of flow cytometric analysis

utilizing this method is limited.

Special considerations

for the use of flow cytometric analysis must be made
following the isolation of cell subpopulations using
antibody and complement.

Similar, if not identical antibody

binding sites may be measured for immunofluorescence as well
as for complement mediated depletions.

Therefore, residual
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Figure 9.
Flow cytometric histograms representing rIL-2 activated
population following in vitro antibody and complement depletions. rIL-2 activated populations were treated with antiLyt-2. 2 or anti-NK 1.1, and complement; or complement alone.
Cells were then assessed for expression of Lyt-2.2 and NK
1.1 phenotypic markers. The left column shows rIL-2
activated populations stained with anti-Lyt-2.2 and the
right column shows rIL-2 activated populations stained with
anti-NK 1.1. The first row shows complement treated rIL-2
activated populations, the middle row rIL-2 activated
populations treated with anti-Lyt-2.2 and complement, and
the third row shows rIL-2 activated populations treated with
anti-NK 1.1 and complement. Data are representative of 3
independent experiments.
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antibody to the cell population may block antigen expression
as determined by flow cytometric analysis.

Flow cytometric

analysis was supported with analysis of percentage
recoverable cells following antibody and complement
depletions.

The percentage of rIL-2 activated populations

not expressing Lyt-2.2 as judged by flow cytometric analysis
was 46.7 ± 8.3%.

Following Lyt-2.2 antibody and complement

treatment, the percentage of recoverable cells was 47.3
5.9% in 3 separate experiments.

±

The decrease in the percent

recoverable cells following anti-Lyt-2.2 and complement
treatment to a level near the original percentage of cells
not expressing Lyt-2.2 indicates that antibody and
complement removed nearly all cells expressing Lyt-2.2.
Likewise, the percent of recoverable cells following NK 1.1
antibody and complement treatment was 74.7 ± 7.4%,
approximately equal to the percentage of cells not
expressing the marker {63.2 ± 6.1%) (Tables I and II).
These data are consistent with the expression of Lyt2. 2 and NK 1.1 on separate cellular subsets within the rIL-2
activated population.

c.

Functional role of Lyt-2.2 and NK 1.1 depleted
populations
The role of Lyt 2.2+ and NK 1.1+ cell populations in

anti-fungal and anti-tumor cytotoxic activity was assessed
following antibody and complement depletions of rIL-2
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Table II. Percent recovery of rIL-2 activated population
following treatment with antibody and complement.

•Mean

± s.

Effector
Population

% Recovery

Untreated

100.0

±

3. 6.

Complement

89.0

±

6.1

anti-Lyt-2.2 +
Complement

47.3

±

5.9

anti-NK 1.1 +
Complement

74.7

±

7.4

D. of 3 independent experiments.
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activated populations.
Populations depleted of Lyt-2.2 displayed significantly
iower activity against both g. albicans and P815 when
compared to rIL-2 activated populations or complement
treated controls (p<0.05)

(Figure 10).

In contrast, NK 1.1

depleted populations showed no difference in anti-fungal and
anti-P815 activity when compared to either complement
treated rIL-2 activated populations or untreated rIL-2
activated population.

The activity of the NK 1.1 depleted

population against the YAC-1 cell line was significantly
reduced {p<0.05) yet still retained activity.

No difference

in activity against YAC-1 was observed between the anti-Lyt2. 2 treated population and either complement treated rIL-2
activated populations or untreated rIL-2 activated
populations (p>0.05).

D. Functional activity of NK 1.1+ and Lyt-2.2+ selected
populations
To confirm the experiments described above, Lyt-2.2+ or
NK 1.1+ populations were selected by immunomagnetic beads
and specific antibody 18 h prior to the assessment of antifungal and anti-tumor activity.
Against both

g. albicans and P815, NK 1.1 selected

cells (NK 1.1+ cells) and Lyt-2.2 unselected cells (Lyt-2.2·
cells) displayed significantly reduced tumor cytotoxic and

g. albicans growth inhibitory activity when compared to rIL-
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Figure 10.
Fungal growth inhibition and tumor cell cytotoxicity of rIL2 activated population after in vitro antibody and
complement depletions. rIL-2 activated populations were
treated with complement plus anti-Lyt-2.2 or anti-NK 1.1
complement alone, or untreated. A. ~. albicans growth
inhibition was assessed by the incorporation of [ 3H]
uridine. Data are presented as % inhibition and inhibitory
units per 107 cells at 20% inhibition (IU). B. YAC-1
critotoxicity is expressed as % cytotoxicity as judged by
7
[ 1Cr] release and by lytic units per 10 cells at 20%
cytotoxicity (LU). c. P815 cytotoxicity is expressed as%
cytotoxicity as judged by [ 51 Cr] release and by lytic units
per 107 cells at 20% cytotoxicity (LU). *, (p<0.05)
Significant difference between activity of Lyt-2.2 antibody
and complement treated rIL-2 activated populations compared
to activity of untreated, complement treated, NK 1.1
antibody and complement treated rIL-2 activated populations;
**, (p<0.05) Significant difference between activity of NK
1.1 antibody and complement treated rIL-2 activated
populations to activity of untreated, complement treated, or
Lyt-2.2 antibody and complement treated rIL-2 activated
populations. Data are expressed as the mean ± s. D. of 3
independent experiments.
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Figure 11.
Fungal growth inhibition and tumor cell cytotoxicity of rIL2 activated population after in vitro selection with immunomagnetic beads and specific antibody. rIL-2 activated
populations were selected with anti-Lyt-2.2 or anti-NK 1.1
and immunomagnetic beads, or unselected populations which
remained following selection of NK 1.1 or Lyt-2.2 and
immunomagnetic beads, or immunomagnetic beads alone. A. g.
albicans growth inhibition was assessed by the incorporation
of [ 3H] uridine. Data are presented as % inhibition and inhibitory units per 107 cells at 20% inhibition (IU). B.
YAC-1 cytotoxicity is expressed as % cytotoxicity as judged
by [ 51 Cr] release and by lytic units per 107 cells at 20%
cytotoxicity (LU). c. P815 cytotoxicity is expressed as%
cytotoxicity as judged by [ 51 Cr] release and by lytic units
per 107 cells at 20% cytotoxicity (LU).
*, (p<0.05)
Significant difference of activity between either Lyt-2.2
selected or NK 1.1 unselected rIL-2 activated populations
compared to untreated rIL-2 activated populations, Lyt-2.2
unselected, or NK 1.1 selected populations.
**, (p<0.05)
Significant difference of activity between either Lyt-2.2
unselected or NK 1.1 selected rIL-2 activated populations
compared to untreated rIL-2 activated populations, Lyt-2.2
selected, or NK 1.1 unselected populations. Data are expressed as the mean ± S. D. of 3 independent experiments.
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activated populations (p<0.05, Figure 11). In contrast,
2
siqnif icant enrichment of activity against both ~. albicans
and P815 was observed by both Lyt-2.2 selected cells (Lyt2.2+) and NK 1.1 unselected pr depleted cells (NK 1.1")
(p<0.05).

The activity of these populations was

significantly enhanced (p<0.05) compared to untreated rIL-2
activated populations, NK 1.1+ selected cells, and Lyt-2.2·
unselected (depleted) cells.

The cytotoxic activity of the

NK 1.1· population against the YAC-1 cell line was
significantly reduced (p<0.05) when compared to all other
populations examined, yet retained activity.

Selected and

remaining unselected populations were examined for
expression of Lyt-2.2 or NK 1.1 as judged by direct
microscopic fluorescence.

Lyt-2.2+ selected populations and

NK 1.1·unselected populations contained insignificant
percentages of NK 1.1+ expressing cells.

Lyt-2.2·unselected

populations and NK 1.1+ selected populations contained less
than background levels of expression of Lyt-2.2 (Table III).
These data confirm the complement-depletional studies
and demonstrate that the Lyt-2.2+ population mediates the
anti-~.

albicans and anti-P815 activity of the rIL-2

activated population while both Lyt-2.2+ and NK 1.1+
populations mediate anti-YAC-1 activity.
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Table III. Percentage of rIL-2 activated population
expressing Lyt-2.2 or NK 1.1 following selection with
inununomagnetic antibody.
Effector
population

% Lyt-2. 2•

% NK 1.1

Lyt-2.2+
(selected)

> 95%

4.5

Lyt-2. 2(unselected)

3.1 + 1. 7d

N. D. e

NK 1.1 +
(selected)

5.0 + 3.6

> 95%

NK i.1(unselected)

N.

As judged
Mean ± S.
c Secondary
d secondary
e Not Done.
a

b

o.

±

3. 4bc

4.2 + 2.2

by microscopic immunofluorescence.
D. of three experiments.
background 4.3 ± 3.1%.
background 5.7 ± 2.6%.

86

g;U,d Target Inhibition of Anti-fungal and Anti-tumor

-

Activity
To assess whether the same cell population is capable

of binding both fungal and tumor targets, cold target
inhibition studies were performed.
In all experiments, homologous inhibitors provided
maximum inhibition of their respective targets (Figure 12).
In all studies, control populations for nonspecific
inhibition were naive thymocytes.

No cold target inhibition

by thymocytes was observed in any experiment.
depicts cold target inhibition of

~.

Figure 12A

albicans.

Both P815

and YAC-1 demonstrated the ability to inhibit the activity
of rIL-2 activated populations against

~.

albicans.

The

competitive activity of both tumor cell lines was
significant when compare to that of naive thymocytes
(p<0.05, Figure 12A).

Cytotoxic activity against the YAC-1

tumor cell line was inhibited by both the P815 tumor cell
line and to a lesser extent by
by both P815 and

~.

~.

albicans.

The inhibition

albicans was significant at p<0.05 at

the three highest ratios examined (Figure 12B).

The cold

target inhibition of the P815 cell line was nearly complete
by the YAC-1 cell line with the inhibition significant at
p<0.05 (Figure 12C).

~.

albicans significantly inhibited

cytotoxicity for the P815 tumor cell line (p<0.05) (Figure
12C).

To assure that the cold target populations were not

mediating the inhibition through released factors, culture
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Figure 12.
Unlabeled target competition studies with g. albicans, YAC1, and P815. rIL-2 activated population were utilized at a
40 : 1 effector : target ratio for % competitive inhibition.
A. Competitive inhibition of anti-fungal activity by g.
albicans, YAC-1, and P815 as assessed by the uridine method.
B. Competitive inhibition of Yac-1 cytotoxicity by g.
albicans, YAC-1, and P815 as assessed by [ 51 Cr] release. c.
Competitive inhibition of P815 cxtotoxicity by g. albicans,
YAC-1, and P815 as assessed by [ 1CrJ release. Unlabeled
homologous target inhibitors were shaded with squares
representing g. albicans, circles representing YAC-1, and
triangles representing P815. Thymocytes (diamonds) were
utilized as irrelevant targets. Data are expressed as the
mean ± s. D. of percent competitive inhibition for 3
independent experiments.
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su P

ernates from the target cell populations were collected

and assessed for inhibitory activity.

No effect on

cytotoxic or inhibitory activity was observed for supernates
coata not shown).
These data suggest that the rIL-2 activated population
which binds to g. albicans also binds to P815 and YAC-1.
Reciprocally, the rIL-2 activated population subpopulation
which binds and mediates anti-tumor activity also binds g.
albicans.

Role of Cell Contact in

c.

albicans growth inhibition by

rIL-2 activated population
A· g. albicans growth inhibitory activity of cellular
supernates
To assess the anti-fungal activity of secreted
substances and evaluate the necessity for cell contact in
anti-fungal activity, rIL-2 activated population supernates
and cellular sonicates were assessed for g. albicans growth
inhibition.
Supernates concentrated 75 fold from populations
treated for 3 h with

g. albicans hyphae were assessed for g.

albicans growth inhibition (Figure 13A).

200 - 12 µl of g.

albicans stimulated supernates displayed an anti-g. albicans
activity in a dose dependent manner (200 µl of concentrated
supernate is equivalent to the supernate of 3.75 x 10 7
cells).

Unstimulated culture supernates (concentrated 75
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Figure 13.
Effect of rIL-2 activated population supernates and whole
cell sonicates upon g. albicans. g. albicans growth
inhibition was assessed by the uridine method and presented
as % inhibition and IU. A. Concentrated supernates (200 ul
to 12 ul) from g. albicans treated rIL-2 activated
population, untreated rIL-2 activated population, and supernates from tissue culture media containing 1500 U/ml rIL-2
were assessed for c. albicans growth inhibition and compared
to intact rIL-2 activated population activity. B. Activity
of sonicates from g. albicans treated rIL-2 activated
population, untreated rIL-2 activated population, day o
spleen sonicates, and day o thymocytes were assessed for g.
albicans growth inhibition at equivalent cellular ratios of
50:1 to 1:1, and compared to the intact rIL-2 activated
population activity. *, (p<0.05) Significant difference
between g. albicans growth inhibition of stimulated or
unstimulated supernates or sonicates from rIL-2 activated
populations compared to untreated rIL-2 activated
populations (significant decrease in inhibitory activity) or
control populations (significant increase in inhibitory
activity). Data are expressed as the mean ± s. D. of 3
independent experiments.
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fold) also possessed inhibitory activity against Q. albicans
when compared to the inhibitory activity of supernates of
cell culture media (with rIL-2) concentrated 75 fold
(p<0.05).
These data demonstrate that Q. albicans stimulated rIL2 activated populations secrete substances which possessed
activity against Q. albicans.

However, the anti-Q. albicans

was 225-fold less active than the intact rIL-2 activated
population.

A finding consistent with a requirement for

cell contact for optimal Q. albicans growth inhibitory
activity.

B. Q. albicans growth inhibitory activity of cellular
sonicates
Cellular sonicates prepared from rIL-2 activated
populations produced an enhanced Q. albicans growth
inhibition when compared to the concentrated supernates
(Figure 13).

Cell sonicates, equivalent to splenocyte

numbers utilized for assessment of activity, from either Q.
albicans stimulated or unstimulated rIL-2 activated
populations produced moderate inhibitory effects against Q.
albicans.

The activity of either stimulated or unstimulated

sonicates was significantly higher (p<0.05) than sonicates
from either day

o

splenocytes or thymocytes.

In contrast,

the activity of either stimulated or unstimulated sonicates
was significantly less (p<0.05) than the activity of rIL-2
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activated populations.
These data demonstrate that cellular sonicates are one
sixth as efficient in mediating

~.

albicans growth

inhibition as the intact population, indicating an intact
cell is required for maximum

~.

albicans growth inhibition.

c. Role of protease inhibitors in anti-fungal and antitumor activity
Contact and an intact cell are required for maximally
efficient anti-fungal activity.

Proteases are associated

with contact-mediated cytotoxic activity for tumor cells.
Therefore, three protease inhibitors were analyzed for their
ability to inhibit the anti-tumor and anti-fungal activity
of rIL-2 activated populations.
Figure 14 depicts the inhibition of anti-tumor and
anti-fungal activity during treatment with the protease
inhibitors, aprotinin 10%, PMSF 300 ug/ml, and TAME lOuM.
Aprotinin produced a marked (p<0.05) decrease in activity
for all targets examined when compared to rIL-2 activated
populations.

PMSF treated rIL-2 activated populations

displayed numerically reduced activity for both

~-

albicans

and P815 when compared to untreated rIL-2 activated
populations.

PMSF treated rIL-2 activated populations were

unaffected in their activity for YAC-1.

In contrast to PMSF

and aprotinin, TAME treated rIL-2 activated populations
showed no inhibition of anti-fungal or anti-tumor activity
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Figure 14.
Fungal growth inhibition and tumor cell cytotoxicity of rIL2 activated population during treatment with protease inhibitors. rIL-2 activated populations and targets, as well
as both g. albicans alone and rIL-2 activated populations
alone were treated with aprotinin 10% (APRO), TAME lOuM
(TAME), and PMSF 300 ug/ml (PMSF), or untreated (day 7). A.
g. albicans growth inhibition was assessed by the incorporation of [ 3H] uridine. Data are presented as % inhibition
and inhibitory units per 107 cells at 20% inhibition (IU).
B. YAC-1 cytotoxicity is expressed as % cytotoxicity as
judged by [ 51 Cr] release and by lytic units per 107 cells at
20% cytotoxicity (LU). c. P815 cytotoxicity is expressed as
% cytotoxicity as judged by [ 51 Cr] release and by lytic units
per 107 cells at 20% cytotoxicity (LU). Targets without
effectors were treated with appropriate protease inhibitors
and utilized to determine maximal incorporation of [ 3H]
uridine for inhibition calculations. No differences in
uptake of [ 3H] uridine were observed between treated targets
without effectors and untreated targets without effectors
(p>0.05), nor did treated effectors without targets display
loss of viability as judged by trypan blue. *, (p<0.05)
Significant difference between activity of aprotinin treated
rIL-2 activated populations compared to untreated rIL-2
activated populations.
Data are expressed as the mean ± s.
D. for 3 independent experiments.
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against either YAC-1, P815 or g. albicans as compared to the
activity of untreated rIL-2 activated populations.

The

protease inhibitors were not directly cytotoxic.
pretreatment of rIL-2 activated populations with these
protease inhibitors for 1 h failed to reduce the anti-fungal
and anti-tumor activity (Data not shown).
These data demonstrate the anti-fungal and anti-tumor
activity of rIL-2 activated populations to be affected by
the serine protease inhibitor, aprotinin.

o.

Effect of protease inhibitors on cellular sonicate and
supernate activity
Sonicates and supernates treated with protease

inhibitors from g. albicans stimulated populations were
assessed for g. albicans growth inhibitory and anti-tumor
cytotoxic activity either with or without the protease
inhibitors PMSF (300 ug/ml) or aprotinin (10%) (Figure 11).

g. albicans growth inhibitory activity of rIL-2
activated population supernates (8.5 ± 2.5 IU) was not
different when compared to supernates of rIL-2 activated
populations treated with either PMSF or aprotinin.

No

difference in tumor cytotoxic activity was displayed by rIL2 activated population cell supernates {14.3

±

2.6 LU for

YAC-1, 12.2 ± 2.3 LU for P815) compared to rIL-2 activated
population supernates treated with either PMSF or aprotinin.
Cellular sonicates of the rIL-2 activated population
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Figure 15.
Fungal growth inhibition and tumor cell cytotoxicity of cell
supernates and sonicates during treatment with protease inhibitors. Cell sonicates {open symbols) at 50:1 to 6:1
equivalents and concentrated supernates (closed symbols) expressed at 200 ul to 50 ul, from ~. albicans stimulated rIL2 activated populations, were treated with aprotinin 10% ( ,
) PMSF 300 ug/ml ( , ) or untreated ( , ). A.~. albicans
growth inhibition was assessed by the incorporation of [ 3H]
uridine. Data are presented as % inhibition and inhibitory
units per 107 cells at 20% inhibition (IU). B. YAC-1
critotoxicity is expressed as % cytotoxicity as judged by
7
1
( Cr] release and by lytic units per 10
cells at 20%
cytotoxicity (LU). c. P815 cytotoxicity is expressed as%
cytotoxicity as judged by [ 51 Cr) release and by lytic units
per 107 cells at 20% cytotoxicity (LU) . Data are expressed
as the mean ± s. D. for 3 independent experiments.
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demonstrated activity against all target populations (63.1 ±
g.3 IU

±

for~-

albicans, 105.5 ± 13.2 LU for YAC-1, and 115.2

1J.6 LU for P815).

The protease inhibitors had no effect

on the sonicates.
These data indicate that the protease inhibitor acts
only against the intact cell and not any soluble factor
released from the cell.

DISCUSSION

Fungal infections in general and g. albicans infections
in particular are important causes of morbidity and
mortality in immunocompromised individuals.

This study

evaluated a novel mechanism by which to limit the
development of fungal disease.

It has been very difficult

to understand the means by which the mammalian host deals
with limiting the growth of fungal hyphae which reach
lengths of 100 µm or larger, in vivo (Soll, 1985).

It is

the hypothesis of this study that lymphocytes influence the
growth of fungal hyphae.

If true, then such cells may

provide an important host defense mechanism by which fungi
may be limited when normal defense mechanisms are disrupted.
It was the purpose of this investigation to clearly identify
the immunological nature, functional activity and laboratory
conditions by which to generate anti-fungal effector lymphocytes.

This identification will permit a direct

assessment of the potential in vitro biological activity of
the lymphocyte cell population and will serve as the
groundwork for a better understanding of the mammalian host
response to g. albicans.

100

101
A review of the literature shows that a correlation
exists between in vivo resistance to g. albicans, the
production of IL-2 and IFN gamma, and the genotype of
specific inbred strains of mice (Ashman et al., 1990).

In

that study, resistance to g. albicans did not correlate with
phagocytic cell activity of the murine strains (Marquis et
al., 1986).

Therefore, non-phagocytic cell populations from

C57Bl/6 mice were evaluated for g. albicans growth
inhibition.

Due to the importance of the hyphal form of the

fungus in disseminated infections, g. albicans growth
inhibition was assessed against hyphae.

Lymphoid cells with

functional and phenotypic characteristics similar to
"activated" T lymphocytes were found to inhibit the growth
of the hyphal form of g. albicans (Figures 9-11).

Lymphoid

cells derived from mice and immediately assessed for hyphal
growth inhibition showed little or no activity (Figures 12).

This finding is consistent with previously published

data {Djeu et al., 1988; Djeu and Blanchard, 1987).
However, significant hyphal growth inhibition was observed
when lymphoid cells were cultured with high concentrations
of recombinant interleukin-2 (rIL-2) (Figures 3-7).

Growth

inhibitory activity was mediated by non-adherent lymphocytes
which had the capacity to lyse the NK susceptible YAC-1 cell
line and the NK resistant P815 cell line.

Phenotypic marker

selection showed the lymphocyte cell population to express
Thy-1.2, Lyt-2.2, and ASGM-1.

Other investigators have
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failed to demonstrate lymphocyte mediated activity against
g. albicans (Baccarini et al., 1983; Djeu and Blanchard,

1987).

Those investigators have either used freshly iso-

lated lymphocytes or lymphocytes activated with low
concentrations of cytokines to inhibit

~.

albicans growth

(Baccarini et al. 1983; Djeu and Blanchard, 1987).

The

results of this study are consistent with those previous
observations but demonstrate that greater concentrations of
rIL-2 are required to "activate" or enhance the capacity of
lymphocytes to mediate growth inhibition of the fungus.
With greater quantities of rIL-2 it is possible to
"activate" lymphocytes, and/or expand a population of
lymphokine activated cells which mediate fungal growth
inhibition.
Multiple methodologies have been published with which
to assess activity against

~.

albicans including;

51

Cr

release from the fungus, and direct microscopic examinations
(Baccarini et al., 1985; Hashimoto, 1983).

Although

accepted methodologies, neither permits easy assessment of
large sample numbers.

Therefore, an alternative method was

developed by which to measure growth inhibitory activity.
This procedure is based upon previously published
methodology (Yamamura et al., 1977), but includes an
extremely important additional step which enzymatically
removes the adherent

~.

albicans from plastic surfaces.

enzyme employed is lyticase.

Lyticase cleaves beta 1,3

The
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linkages of glucose, which are found in glucan, a major
constituent of the cell wall of

g. albicans.

Alteration of

the cell wall by lyticase reduces the binding capacity of g.
albicans to plastic (Kennedy et al., 1989; Hazen, 1989), and
allows for easy harvest of the fungi with a PhD cell
harvester.

Therefore, large numbers of experimental samples

can be processed in a manner similar to the harvesting
procedure for lymphoproliferation assays.

The assay

employed measures the incorporation of [ 3H] uridine by
albicans as an index of fungal cell growth.

g.

Very little is

known about the metabolism of RNA during g. albicans growth.
Wain et al.

(1976) demonstrated that the RNA content, as

measured by ( 3H] uridine uptake by

g. albicans, increases

continuously throughout the cell cycle.
form of RNA found in
Soll, 1984).
been reported.

The predominant

g. albicans is ribosomal (Anderson and

No measurement of messenger RNA synthesis have
Nevertheless, following the conclusion of

the three hour co-incubation period, [ 3H] uridine uptake is
at a steady state of accumulation (Soll, 1985).

The

inhibition of [ 3H] uridine uptake directly reflects
alteration of normal

g. albicans growth (Soll, 1985).

The

assay system utilized takes advantage of this steady state
incorporation of uridine and with the use of lyticase and
the PhD cell harvester, is a simple, convenient and
reproducible procedure.

Furthermore, the obtained

experimental results are similar to those of previously

104
published methodologies (Baccarini et .sU..., 1985; Hashimoto,
1983; Beno and Mathews, 1990).
Anti-g. albicans activity is presented as a percent
inhibition of hyphal growth as described previously (Nabavi
and Murphy, 1985).

The hyphal form predominates in tissues

infected with g. albicans and is therefore considered to be
the most relevant for examination.

The assay utilized for

assessment of growth inhibitory activity was developed to
reflect inhibition within a three hour period.

Whether the

assay truly measures growth inhibition or is in fact a
measure of direct cytotoxic activity is unknown.

The

decrease in countable disintergrations in the experimental
samples might reflect cytotoxic activity.

However this can

not be directly assessed by the results of this assay.

The

decrease in countable disintergrations can only be associated with a change in the steady state incorporation of
[

3

H] uridine.

The decrease in radioisotopic incorporation

has been associated with a decrease in RNA accumulation,
protein synthesis, and cell proliferation (Anderson and
Soll, 1984).

Whether this is inhibition of the hyphal

fragments resulting from damage of one or more of the
individual segments of the organism or death of the entire
organism is unknown.

Regardless, the g. albicans activity

does not lead to complete destruction of the fungi in that
countable disintergrations are incorporated in all
experimental cases.

Therefore, the lowered incorporation of
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[3HJ uridine is defined as growth inhibition.

NK activity (as judged by anti-YAC-1 cytotoxicity) was
present in murine splenocytes (Figure 1).

g.

In contrast, no

albicans growth inhibition was detectable in murine

splenocytes (Figure 1) .

These findings are consistent with

previous studies which indicated no anti-g. albicans
activity in murine splenocyte populations (Vecchiarelli et
al., 1985; Zunino and Hudig, 1988).

NK activity is

associated with a morphological cell type, the large
granular lymphocyte (LGL)

(Ortaldo and Longo, 1988).

LGL

can been isolated in high purity from discontinuous Percoll
gradients or enriched by passage over nylon wool columns
(Hidore and Murphy, 1986).

To enrich for NK activity, day

zero splenocytes were subjected to discontinuous percoll
separation.

Low density fractions which contained high

concentration of LGLs showed a significant increase in NK
activity when compared to the unseparated splenocyte
population.

No increase in g. albicans growth inhibition

was observed with the LGL enriched cell population (Figure
2).

Splenocytes were also depleted of adherent cells by

passage over nylon wool columns as well as by adherence to
plastic.

NK enrichment and macrophage depletion by these

procedures resulted in cells with no g. albicans growth
inhibitory activity, despite an increase in NK activity when
compared to untreated splenocyte populations.

These data

are consistent with previous studies indicating no
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enrichment of Q. albicans growth inhibition in cell
populations enriched for NK activity (Djeu et al., 1988;
zunino and Hudig, 1988).
Previous studies using human LGL isolated from PBMCs
failed to demonstrate g. albicans inhibitory activity
following activation with low levels of rIL-2 (Djeu and
Blanchard, 1987) •

rIL-2 activated human LGLs did not

produce growth inhibition of g. albicans following
activation with 100 U/ml rIL-2 for 18 h (Djeu and Blanchard,
1987).

The current study found that murine splenocytes

activated with 1500 U rIL-2 for 24 h showed no significant
increase in g. albicans inhibitory activity despite a
significant increase in NK activity (Figure 3).

Splenocytes

cultured for one day in culture medium without rIL-2 had no
activity against g. albicans or P815 and the level of
activity against YAC-1 was significantly lower than either
day zero or day one.

These data are consistent with

previous findings demonstrating that splenocytes activated
for a short time period with rIL-2 possess an enhanced NK
activity but do not mediate g. albicans growth inhibition
(Djeu and Blanchard, 1987).

However, the results of this

dissertation do demonstrate that with increased
concentrations of rIL-2, the capacity to inhibit g. albicans
is acquired by lymphocytes and is associated with the
capacity to lyse NK sensitive and insensitive tumor cell
lines (Figures 4, 5).

These data are unique.

No other
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investigations have identified an enhanced

&· albicans

growth inhibition following rIL-2 activation.
This study sought to identify the length of time
required for in vitro culture to acquire maximal
growth inhibitory activity.

&.

The appearance of the

albicans

&·

albicans growth inhibition coincided with the development of
cytotoxic activity for the NK resistant tumor target, P815,
and enhanced activity against the NK susceptible tumor
target, YAC-1 (Figure 6).

To identify the length of culture

required for maximal cell recovery following activation with
rIL-2, cell recovery and proliferation rate were evaluated.
Splenocyte recoverability dramatically decreased following
two days in culture with rIL-2 (Figure 7).

Previous studies

have demonstrated the loss of B lymphocytes and T helper
lymphocytes over time in culture with rIL-2 (Peace et al.,
1988).

In the current study, as the recoverability

decreased the rate of proliferation increased.
Proliferation began at day two and peaked by day four.
Proliferation failed to continue after day seven in this
study.

This finding is similar to the studies of Mule et

al. (1987), who found no proliferation following eight days
in culture with rIL-2.

Splenocytes activated in rIL-2 for

seven days were chosen for further study because both
maximal cell numbers and anti-fungal activity were observed
at this time period.
The extended culture period may permit the development
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of a population with broad tumoricidal reactivity as
evidenced by the concomitant appearance of cytotoxic
activity for the NK insensitive cell line, P815.

The

development of this population could be the consequence of
several factors.

First of all, expansion of rIL-2

responsive populations which mediate

c. albicans growth

inhibition and anti-tumor activity may occur.

Yang et al.

(1986) found a concomitant decrease in the number of IL-2
unresponsive lymphocytes in such culture which paralleled an
increase in the number of lymphocytes which were responsive
to rIL-2.

Alternatively, activation of an existing anti-

fungal cell population may require an extended culture
period for maximal activity.

Studies by Merluzzi (1985)

indicate that at least three days of rIL-2 activation are
required for induction of anti-P815 activity with seven days
required for maximal activity.

Other studies of rIL-2

activation demonstrate that three to five days of culture
are required for maximal tumoricidal activity (Grimm et al.,
1982; Lafreniere et al., 1986).

The results of this

dissertation did not demontrate an absolute requirement for
the expansion of the rIL-2 activated population which
mediates the

~-

albicans growth inhibition.

However, the

expansion of this populaiton cannot be dismissed due to the
observed changes in cellular proliferation, cell recovery,
and cellular phenotype during activation with rIL-2 (Figure
7, Table I).

The results of this dissertation are
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consistent with the activation of a rIL-2 activated
population which mediates

~.

albicans growth inhibition.

Thus far this investigation has demonstrated that
following extended activation with rIL-2, a population of
lymphocytes arises which mediate
inhibition.

~.

albicans growth

The seven day rIL-2 activated cell population

also mediates anti-tumor activity against both the NKsensitive tumor cell line YAC-1, and the NK-insensitive
tumor cell line P815.

~.

albicans growth inhibition does

correlate with the acquisition of both anti-P815 and
enhanced anti-YAC-1 activity suggesting that a MHCunrestricted cytotoxic lymphocyte population is a portion of
the cell population responsible for the observed
growth inhibition (Figures 3-5).
lymphocyte mediated

anti-~.

~.

albicans

Other studies of

albicans activity have not

observed anti-fungal activity because the requisite
activation and expansion of the anti-fungal cell population
was not permitted (Vecchiarelli et al., 1985; Zunino and
Hudig, 1988).

The current study demonstrates that seven

days are required for maximal activation with 1500 U rIL-2.
The results of this study demonstrate that activation
of splenocytes with rIL-2 augments not only the anti-tumor
and anti-fungal activity of splenocytes, but also alters the
phenotypic makeup of the cell population (Table I).
Increased numbers of cells expressed the specific surface
markers Thy-1.2, ASGM-1, Lyt-2.2, and NK 1.1 while cellular
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expression of Ig and L3T4 decreased to background levels.
This phenotypic marker expression has been demonstrated
previously to be a consequence of rIL-2 activation (Yang et
gj.., 1986).

Previously, rIL-2 activation of lymphocytes has been
shown to induce MllC-unrestricted cytotoxic reactivity in
vitro, which is mediated by lymphocytes expressing both Thy1. 2 and ASGM-1 phenotypic markers (Ballas et al., 1987;
Merluzzi et al., 1986).

Thy-1.2 is known to be expressed by

lymphocytes with broad cytotoxic activity (Yang et al.,
1986; Thiele and Lipsky, 1989) while ASGM-1 is present on a
variety of cell types (Mule et al., 1989) and it's
expression has been shown to correlate directly with
activation of MllC-unrestricted cytotoxic lymphocytes (Stout
et al., 1987).

Within the limits of experimental error, all

seven day rIL-2 activated populations in this study
expressed Thy-1.2 (Table I).

In a similar manner, ASGM-1

was shown to be expressed by nearly all cells comprising the
rIL-2 activated population (Table I).

Therefore, ASGM-1 and

Thy-1.2 are expressed simultaneously by the lymphocytes
which comprise the rIL-2 activated population.

This data is

consistent with the scientific literature and the clear
expression of both

ASGM-1 and Thy-1.2 by the rIL-2

activated population.
The results of flow cytometric analysis (Table I)
suggested the possible differential expression of Lyt-2.2
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and NK 1.1 by cells within the rIL-2 activated population.
Anti-NK 1.1 specifically identifies mature NK and other MHCunrestricted cytotoxic lymphocytes in certain murine
strains, including C57Bl/6 (Koo and Peppard, 1984}, whereas
antibody to Lyt-2.2 identifies cytotoxic T lymphocytes
(Kalland et al., 1987).

The current investigation sought to

determine whether the anti-fungal activity segregated with a
particular cellular phenotype within the rIL-2 activated
population of cells.

The differential expression of Lyt-2.2

and NK 1.1 was exploited to identify the phenotypic
character of the rIL-2 activated population which mediates

g. albicans growth inhibition.

The results of those studies

suggest that rIL-2 activated population mediating

c.

albicans growth inhibition express Lyt-2.2 and not NK 1.1
(Figures 6, 7, and 8).

Differential expression of NK 1.1

and Lyt-2.2 within the rIL-2 activated population is similar
to the studies of Peace et al. (1988) who showed LAK cells
were divided into at least two mutually exclusive subsets,
1) a cytotoxic T lymphocyte (Lyt-2.2+, NK 1.1*) with MHCunrestricted cytotoxic activity and 2) a NK (Lyt-2.2·, NK
1.1+) cell population with MHC-unrestricted cytotoxic
activity.

The results of this study show that these two

separate and distinct subpopulations exist within the seven
day rIL-2 activated population.

The Lyt 2.2+ lymphocyte

population mediates the anti-fungal activity of the seven
day rIL-2 activated population.
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This study has demonstrated anti-Lyt-2.2 and complement
treatment to obliterate the growth inhibitory activity of
the rIL-2 activated population for the hyphal form of
albicans.

~.

This treatment also reduced the lytic activity of

the cell population for P815 but not YAC-1 (Figure 7).
These data demonstrate the Lyt-2.2+ population to be capable
of activity against

both~.

albicans and P815.

NK 1.1 an-

tibody and complement depleted cell populations mediated
significantly (p<0.05)
inhibition.

increased~.

albicans growth

Statistical analysis of the inhibitory units

(IU) reveals significant differences between the cells
treated with NK 1.1 and complement and complement alone,
despite no apparent visual difference in the effector to
target ratio data.

In calculating the IU based on the lytic

unit calculation, these data are significant because of the
inclusion of the data at 6:1 effector to target ratio.

The

inclusion of this data alters the linear slope of the line
which is used for IU calculation.

Comparisons of NK 1.1 and

complement treated cells with cells treated with complement
alone reveal numerical differences in

~.

albicans growth

inhibition. These differences indicate that the loss of NK
1.1+ cells results in an increase
inhibitory activity.

in~.

albicans growth

These data calculated as IU also

demonstrate that lymphocytes expressing the NK 1.1
determinant do not mediate the
(Figure 7).

~.

albicans growth inhibition
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Although stringent conditions for antibody and
complement mediated depletions were utilized, the completeness of these depletions may not be absolute (Mule et
al., 1989; Kalland et al., 1987).

Furthermore, antibodies

used for such depletion may interfere with cellular
functional activity (Peace et al., 1988).

It is difficult,

and perhaps impossible, to obtain a totally pure cell
populations with any cell separation procedure, and it is
even more difficult to accurately quantify the possible
contribution of contaminating cells (Kalland et al., 1987).
In this study, a small percentage of positively labelled
cells were observed by direct fluorescent microscopy to
remain in depleted cell populations (Table II).

Thus, any

remaining low levels of activity against g. albicans and
P815 might be the result of residual cell populations not
eliminated during complement-mediated depletions.

However,

the complement depletion studies do suggest that Lyt-2.2+
cells mediate g. albicans growth inhibition.

Confirmation

of these data was sought by positive selection of the same
phenotypes.
Figure SA demonstrates that the Lyt-2.2+ rIL-2
activated subpopulation, selected by magnetic antibody and
anti-Lyt-2.2+, mediated significantly enhanced g. albicans
growth inhibition when compared to unselected rIL-2
activated cell populations.

Concomitant with the enhance-

ment of g. albicans growth inhibition was an enrichment in
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anti-PS15 activity (Figure SC).

These data are consistent

with the Lyt-2.2+ cell population mediating activity against
both g. albicans and the PS15 tumor cell line.

No dif-

ferences in anti-YAC-1 activity between the Lyt-2.2+ and
Lyt-2.2· separated populations were observed (Figure SB).
Previous studies have demonstrated rIL-2 activated
lymphocytes expressing Lyt-2.2+ to be capable of anti-YAC-1
cytotoxicity (Kalland et al., 19S7; Gunji et gl., 19S9) as
well as anti-PS15 activity (Sensi et al., 1990).
The NK 1.1-populations showed decreased anti-YAC-1 activity (Figure SB).

This is consistent with previous

studies which demonstrate a majority of anti-YAC-1 activity
resides within the NK 1.1+ population (Kalland et al.,
1987).

The absence of enriched anti-YAC-1 activity in the

NK 1.1+ population is also consistent with previous studies
which demonstrate both NK 1.1+ and Lyt-2.2+ populations to
be capable of anti-YAC-1 cytotoxicity (Peace et al., 19S8;
Gunji et al., 1989).

Figure SA shows decreased g. albicans

growth inhibition by the NK 1.1+ subpopulation selected by
magnetic antibody compared to that of the Lyt-2.2+ selected
subpopulations.

NK 1.1+ selected populations showed sig-

nificantly decreased g. albicans growth inhibition when compared to untreated rIL-2 activated populations.

Concomitant

with the decrease in g. albicans growth inhibition activity
was a decrease in anti-P815 activity (Figure SC).

These

data are consistent with the Lyt-2.2+ cell population
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mediating activity against both
cell line.

~-

albicans and the P815

No anti-fungal activity was observed for NK 1.1+

selected cells.
Lyt-2.2+ expressing cells have been demonstrated to
mediate anti-P815 activity (Sensi et al., 1990).
finding is confirmed by the current study.

This

However, the

lack of NK 1.1+ mediated anti-P815 activity was surprising.
studies have demonstrated NK 1.1+ pan-cytotoxic activity
(Ballas and Rasmussen, 1990).

Those investigations employed

the NK resistent targets, EL-4 and CL27a but not the P815.
The lack of NK 1.1+ effector activity against P815 may
relect differences between these distinct target cell
populations.

However, the data unequivocally demonstrates

the NK 1.1+ cell population to be unable to mediate antiP815 activity (Figure 11).
The magnetic selection of rIL-2 activated
subpopulations was completed on the sixth day of activation
with rIL-2.

This methodology was necessitated by the nature

of the selection process.

The major consideration was the

possible inhibition of biological activity due to stearic
hinderance by antibody-magnetic bead complexes on the cell
surface.

The differential functional activities observed

with subpopulations separated magnetically attests to the
appropriateness of the approach and its' superiority to that
of complement-mediated, antibody depletions.

Complement-

mediated cell lysis, as compared to magnetic separation,
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while based on the same spectrum of available antibodies is
more time consuming, is restricted to cell depletion, and is
less efficient with respect to the viability and purity of
the resulting subpopulation (Pflueger et gl., 1990).
Therefore, populations selected by the magnetic separation
technique were a more reliable index of biological activity.
The combination of data from Figures 6, 7, and 8
demonstrates that Lyt-2.2 and NK 1.1 are not expressed on
the same cells within the seven day rIL-2 activated cell
population.

Both the total percentage of cells expressing

each marker in the rIL-2 activated population along with the
concurrent increase and decrease in the antibody treated
populations argues for separate populations of Lyt-2.2+ and
NK 1.1+ within the total Thy-1+ and ASGM-1+ population.
although a minor population expressing both Lyt-2.2 and NK
1.1 may exist.

The~.

albicans growth inhibition activity

resides in the rIL-2 activated population which expresses
ASGM-1, Thy-1.2 and Lyt-2.2, but not NK 1.1.
These results are consistent with one cell population
mediating both an

anti-~.

albicans and an anti-P815 activity

as well as an anti-YAC-1 activity.

To assess whether the

anti-fungal effector cells within the rIL-2 activated
population also bind tumor targets, cold target inhibition
studies were performed.

Homologous cold targets mediated

complete inhibition of growth inhibitory activity of

~.

albicans as well as cytotoxic activity against tumor targets

117
(Figure 13).

Heterologous cold targets inhibited biological

activity for either tumor or fungal targets in a competitive
and reciprocal manner.

These data provide evidence that the

rIL-2 activated population possesses the ability to
recognize and bind all three targets.

The absolute

resolution of whether a population within the rIL-2
activated population mediates activity against both tumor
targets and

~.

albicans will require the preparation of a

cloned rIL-2 activated population.

At this point, no known

functional clone with similar activity to rIL-2 activated
population is available and attempts to obtained cloned
populations have not succeeded.
The findings of this study suggest recognition of
targets, as judged by incomplete and varying levels of cold
target inhibition, is not identical.

However, similarities

in recognition and binding do exist.

The extent of in-

hibition of g. albicans activity was greater by P815 than
YAC-1 suggesting the rIL-2 activated population which binds
~.

albicans is more reactive with P815 than with YAC-1.

The

greater inhibition by P815 might not necessarily reflect
variation in target recognition, but rather might be a
binding characteristic of the rIL-2 activated population.
The rIL-2 activated population which mediates g. albicans
growth inhibition might be more adhesive for certain tumor
targets than cell populations which do not mediate
albicans growth inhibition.

~.

The phenotyping data indicates
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at least two populations possess activity against YAC-1,
therefore the incomplete inhibition mediated by YAC-1 might
occur because both subpopulations bind YAC-1 while only one
subpopulation of the rIL-2 activated population binds g.
albicans and YAC-1.

Isolation of the Lyt-2.2+ population

and assessment of cold target inhibition is required to
assess this hypothesis.

The reciprocal inhibition of anti-

YAC-1 activity by g. albicans indicates partial recognition
of g. albicans by a portion of the rIL-2 activated
population which mediates activity against YAC-1.

The

inhibition is not complete, further suggesting other rIL-2
activated populations, besides those reactive with g.
albicans, mediate activity against YAC-1.

P815 partially

inhibits YAC-1 activity, which is consistent with one of the
two cytotoxic populations showing activity against YAC-1.
The

c. albicans inhibition of YAC-1 activity is less than

that of P815 competitive inhibition.

The finding of

stronger inhibition by P815 than g. albicans suggests more
similarity between the tumor targets than the fungal/tumor
interaction.

Alternatively, effector to target binding

might occur through different cell surface receptors.

Cold

target inhibition studies of anti-P815 activity revealed
that YAC-1 almost completely inhibits cytotoxic activity,
suggesting recognition of both tumor populations by rIL-2
activated populations.

The above data indicate that the

rIL-2 activated population which mediates g. albicans growth
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inhibition possesses the ability to bind tumor targets.
However, the binding of this population to tumor targets is
not as easily inhibited with

~-

albicans as with tumor

competitors.
The incomplete cold target inhibition observed by
heterologous targets may be explained by several factors.
The lower inhibitory activity of e. albicans tumor target
inhibition may result from the heat inactivation of
albicans.

~

Affected heat labile receptors (Bouchara et al.,

1990) involved in recognition might alter binding of e.
albicans.

Alteration of receptors utilized in binding might

lower the potential binding activity of the hyphae thus
decreasing surface receptors, leading to less cold target
inhibitory capability.

Killing the

necessitated for several reasons.

~.

albicans was

First of all, live

~.

albicans possess the ability to incorporate released [ 5ter]
from the target cells.

This would alter the amount of

countable [ 5ter] in the supernate thereby leading to a false
diminution of cytotoxic activity.

Secondly,

~-

albicans

growth would alter the effector to target ratio during the
assessment of cytotoxicity.

Another consideration is the

possible release of factors by

~.

albicans which may alter

the binding and/or cytotoxic mechanism of tumor activity.
Incomplete inhibition of

~.

albicans activity by cold tumor

targets may also result from the characteristic growth of
albicans in culture.

The growth and elongation of

~.

~
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albicans is accompanied by expansion of the hyphal length in
culture.

Growth increases the total surface area of the

hyphae, allowing expression of more receptors for which rIL2 activated populations may bind and mediate anti-fungal
activity.

As the assay continues the targets become larger,

providing more binding sites and in effect, additional
targets.

Alternatively, the adherence of the hyphae on the

plastic surf aces may provide a mechanism which allows
preferential binding of rIL-2 activated populations to
albicans rather than the tumor targets.

c.

~.

Seeded and anchored

albicans might preferentially enhance rIL-2 activated

population binding.
construction of the

Another possible explanation is the
~.

albicans hyphae.

It consists of

separate organisms within the hyphae joined by an incomplete
septum (Soll, 1985).

Multiple hits on each hyphae may be

required for growth inhibitory activity.

This may force the

rIL-2 activated population to remain longer on each hyphae
before growth inhibition is observed.

Furthermore, the

mechanism of inhibition may require a longer time period
before growth inhibition is observed and once bound, rIL-2
activated population may not dissociate from the cell wall
and locate another target as quickly as in a tumor system.
The incomplete inhibition of the fungus by rIL-2 activated
populations affecting tumor targets could be the result of
these physical and kinetic differences in

~.

albicans-rIL-2

activated population binding compared to tumor cell-rIL-2
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activated population binding.

In contrast to the simple

plasma membrane where direct rIL-2 activated populationtumor cell interactions occur, the outer surface of fungi is
substantially more complex.

Studies of NK-cyrptococcal

interactions have shown NK-cyrptococcal binding requires two
hours prior to initiation of anti-fungal activity while NKYAC-1 binding require only 20 minutes (Murphy, 1989).
Furthermore, Cryptococcus neoformans conjugate formation is
smaller, does not appear to interdigitate, and is generally
much less intimate than is the broad area of interdigitating
membrane contact observed in NK-tumor cell conjugates
(Hidore et al., 1990).

The interaction of the rIL-2

activated population with g. albicans might also require a
longer time period for binding and initiation of anti-fungal
activity thereby leading to the reduced competitive
inhibition observed with g. albicans.
The inhibition of biological activity by heterologous
targets is statistically significant and demonstrates that
both c. albicans and tumor cells competitively and
reciprocally inhibit the activity of the rIL-2 activated
population. These data demonstrate that an effector
population within the rIL-2 activated population recognizes
and mediates activity for two diverse target cell populations, c. albicans and tumor cells.

Previous studies of

fungal interactions of both cryptococcus neof ormans (Hidore
et al., 1990) and C. albicans (Zunino and Hudig, 1988) have
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demonstrated the ability of fungi to cold target inhibit NK
activity.

The current study does not imply similar

mechanisms of binding, it does suggest that rIL-2 activated
population possess the ability to bind all three targets in
a competitive manner.

Furthermore, the activity of the rIL-

2 activated population is inhibited by each of these
targets, suggesting that the rIL-2 activated population
mediates activity against each of these target populations.
The ability to bind all three targets, combined with proven
activity against all three targets suggests a broad
recognition and reactivity of the rIL-2 activated
population.
The mechanism of g. albicans growth inhibition is
either mediated by direct cell contact or indirectly through
secreted factors.

The demonstration of recognition and

binding of rIL-2 activated populations to g. albicans
suggests the anti-fungal activity to be contact mediated.
Therefore, this became the hypothesis for a series of
experiments.

A method for limiting cell contact between

effector and target cells, while allowing interaction of
soluble factors was unavailable.

Therefore, an assessment

of absolute contact could not be accomplished.
A series of experiments was conducted to assess
indirectly the role of cell contact in g. albicans growth
inhibition.

The first of these experiments examined whether

cellular supernates from rIL-2 activated populations
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roediated growth inhibition against g. albicans.
unconcentrated culture supernates from rIL-2 activated
populations possessed no growth inhibitory activity for g.
albicans.

Culture supernates were concentrated 75 fold and

assessed for g. albicans growth inhibition (Figure 9).

rIL-

2 activated populations were stimulated with g. albicans in
an attempt to induce the release of growth inhibitory
molecules.

Stimulated and concentrated supernates possessed

a greater anti-fungal activity than unstimulated and
concentrated supernates.

However the activity was roarkedly

less than that of the intact cell population (p<0.05).

The

stimulation of rIL-2 activated populations with g. albicans
increased growth inhibition, but coropared to intact cells,
the inhibitory activity was negligible.

These data are

consistent with the hypothesis that contact is required for
maximal g. albicans growth inhibition.

Secreted molecules

are not the most efficient mechanism of anti-fungal or antitumor activity (Theile and Lipsky, 1989; Murphy, 1989).
Minimal g. albicans growth inhibition by cell
supernates suggests that growth inhibitory activity is most
efficient when cell associated.

Previous findings have

demonstrated that LAK cells release membrane-damaging agents
which remain cytotoxic for glial cells outside the contact
area of effector target conjugates (Jaaskelainen et al.,
1990).

However tumoricidal studies similar to this

dissertation failed to demonstrate nonspecif ically released
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cytotoxins which generate comparable levels of activity to
intact effector populations {Thiele and Lipsky, 1989).
The lack of supernate activity may be a consequence of
a number of factors, e.g., the process of concentrating the
freshly harvested supernates required three hours.
Proteases may have destroyed functional activity of possible
secreted cytotoxins in the fractions (Theile and Lipsky,
1988).

Alternatively, the target cell, g. albicans, may be

induced by the concentrated supernates to release a variety
of proteolytic enzymes {Wilton and Lehner, 1981).

The

proteolytic enzymes may act in a protective manner to
inactivate anti-g. albicans factors which are present within
the concentrated supernate (Domer, 1989).
The concentration of rIL-2 within the media is not
inhibitory to the measured activity since concentrated
complete media containing rIL-2 failed to inhibit growth
(Figure 13A).

However, the activation of cells over seven

days with rIL-2 could induce inhibitory molecules which
reduce the growth inhibition of g. albicans.

Such

inhibitors might remain functional during the concentration
process and inhibit g. albicans growth inhibition.

These

conditions may prevent supernates from demonstrating maximal

g. albicans growth inhibition.
The results from these studies demonstrate that cellfree supernates concentrated 75 fold from rIL-2 activated
populations stimulated with g. albicans were capable of
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mediating anti-fungal activity, but at a much reduced rate
when compared to intact rIL-2 activated populations.
The failure of cellular supernates to mediate
comparable levels of g. albicans inhibitory activity to
intact rIL-2 activated populations, lead to the next
experimental series which assessed the requirement for an
intact cell population to mediated g. albicans growth
inhibition.

rIL-2 activated populations were disrupted by

sonication until cells were <99% viable as judged by trypan
blue exclusion.

Of primary interest was whether the

disrupted cells possessed the ability to mediate the fungal
growth inhibition.

Therefore, rIL-2 activated populations

used for the sonication experiments were placed in assay
media at concentrations identical to those for assessment of

g. albicans growth inhibition without sonication.

Following

sonication, equivalent starting numbers of sonicated rIL-2
activated populations to control rIL-2 activated populations
were assessed for g. albicans growth inhibition.

The

sonicated cells of both g. albicans stimulated and
unstimulated populations produced activity against fungal
and tumor targets.

However only one sixth of the g.

albicans growth inhibition produced by the intact effector
population was mediated against g. albicans by sonicated
cells.

The failure of sonicated cells to mediate

identical

levels of growth inhibitory activity against g. albicans
suggests that the mediator(s) of

c. albicans growth
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inhibition are less effective at inhibiting
an intact cell.

~-

albicans than

Previous studies of tumoricidal activity

have demonstrated granule extracts to be less efficient with
respect to cytotoxicity than intact cells (Henkart et al.,
1987; Hayes et al., 1989).

The limited activity of granule

extracts may be a consequence of dilution in that the
activity in solution may be less than that of the intimate
surroundings of the microenviroment formed by cell to cell
contact.

This effect is overcome by the polarized secretory

mechanism that delivers a high local concentration of the
active mediators to the appropriate target site (Hayes et
al., 1989).

Henkart et al., (1987) demonstrated that highly

purified granules possess higher tumor cytotoxic activity
than the activity from comparable numbers of unpurif ied
cellular extracts.

The activity of the cellular extracts

was less than the activity of the intact cells.
Furthermore, studies of purified NK granules revealed higher
activity against the fungal target Cryptococcus neoformans
than those of similarly treated unpurif ied extracts (Hidore
et al., 1990).
Limited activity of sonicated rIL-2 activated
populations in the current study could result from the
methodology employed.

For example, the process of

sonication may inactivate any
molecules.

~.

albicans growth inhibitory

Furthermore, despite the presence of ice during

sonication, the increase in temperature may inactivate the
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inhibitory factors.

The release of g. albicans inhibitory

molecules from the stimulated rIL-2 activated populations
which would otherwise possess enhanced activity might lower
the potential inhibition.

Furthermore, remaining

c.

albicans from the stimulation could alter the results in
several ways.

Remnants of g. albicans sonicated with the

rIL-2 activated populations may act in a cold target manner
to bind inhibitory molecules and lower the level of
observable inhibition.

Additionally, the sonicated g.

albicans may release a variety of factors which may bind or
inhibit the inhibitory molecules of rIL-2 activated
populations.

These conditions may prevent cell sonicates

from demonstrating maximal g. albicans growth inhibition.
Cell sonicates from rIL-2 activated populations
stimulated with g. albicans were capable of mediating both
anti-fungal and anti-tumor activity, but at a much reduced
rate when compared to intact rIL-2 activated populations.
The finding that rIL-2 activated populations bind g.
albicans (Figure 12), coupled with the absence of activity
with sonicates (Figure 13A), and the failure of released
mediators to affect fungal growth, suggests, but does not
prove, that cell contact is required for maximal activity
against g. albicans.
Based on the above findings, the implication of contact
mediated activity was further assessed by the use of
protease inhibitors.

Cell surface associated proteolytic
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enzymes (serine proteases and esterases), have been
implicated in the lytic phase of the tumor cell cytotoxicity
reaction (Lavie et g,l. 1985).

Complex cellular mechanisms

triggered by the contact and binding of the target cell via
the receptor are involved in cellular cytotoxicity.
Following recognition of a given target cell, the effector
cell has the ability to activate any or all of several
proteases which induce the cytotoxic mechanism.

Protease

inhibitors are known to diminish cell-mediated cytotoxicity
against tumor cells (Jenne and Tschopp, 1987).

Therefore,

the effect of such inhibitors on rIL-2 activated population
mediated

c. albicans growth inhibition was examined.

Proteases are generally regarded to require cell contact for
functional activity (Jenne and Tschopp, 1988), therefore,
the reduced g. albicans growth mediated by protease
inhibitors in this dissertation implicates a contact
requirement for maximal g. albicans inhibitory activity.
Representative protease inhibitors were selected for
examination because of their differential ability to inhibit
cytotoxic interactions of tumor targets by various effector
populations (Lavie et al., 1985; Jenne and Tschopp, 1988;
Scuderi, 1989).

TAME, aprotinin, and PMSF were assessed.

The concentrations utilized reflect maximum inhibition
following titer evaluation and did not affect incorporation
of [ 3H] uridine by g.

a~bicans

or affect the viability of

the rIL-2 activated population utilized for calculation of
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data.

Aprotinin inhibited rIL-2 activated cell mediated

c.

albicans growth inhibition as well as tumoricidal activity
against all targets examined (Figure 10).

Aprotinin had a

lesser capacity to diminish activity against YAC-1 than it
did against other target cell populations.
the result of a differential effect on
with activity against YAC-1.

This could be

cell populations

Aprotinin is a very stable

molecule which inhibits a variety of enzymes, e.g., trypsin
and chymotrypsin.

Aprotinin binds to the active sites of

the enzyme, forms a tight complex and renders the enzyme
inactive (Hewlett, 1990).

One model of aprotinin-mediated

inhibition is through esterase modification in cytoplasmic
granules (Hayes et al., 1989).

The modification of the

esterase interferes with the regulation of the cytotoxic
machinery and exocytosis of cellular constituents there by
inhibiting cytotoxicity (Hayes et al., 1989; Lavie and
Zucker-Franklin, 1989).

In the current study,

the~.

albicans inhibitory activity as well as the tumor cytotoxic
activity is not completely eliminated by the effect of
aprotinin.

This may be as a result of incomplete saturation

within the area of cell contact.

However, concentration

dependant evaluations failed to lower the remaining activity.

Alternatively, the lack of inhibition may also be

due to other cytotoxic mechanisms which are not inhibitable
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by aprotinin.
residual

~.

Such mechanisms might be responsible for the

albicans growth inhibition of the rIL-2

activated populations.
PMSF inhibited the activity of rIL-2 activated
populations against P815 and

~.

albicans, but not YAC-1.

PMSF has been reported to inhibit activity of both T cells
and NK cells (Jenne and Tschopp, 1988).

PMSF has been

demonstrated to inhibit target cell DNA release by
inhibiting a serine protease activity that resides in a low
pH subcellular compartment, believed to be granzyme A (Hayes
et al., 1989).

Previous studies by that group have also

demonstrated that PMSF substantially inhibits BLT esterase
activity (Henkart et i!l., 1987).

Whether PMSF is inhibiting

either of these proteases in this study is unknown.
ability of PMSF to numerically inhibit growth of

~-

The
albicans

and cytotoxic activity against P815 but not YAC-1, does
suggest a similar population or mechanism of activity is
active in mediating

anti-~.

albicans and anti-P815 activity,

but not necessarily anti-YAC-1 activity.

The inability of

PMSF to reduce activity against YAC-1 might result from
other cytotoxic populations which are not sensitive to PMSF.
PMSF is slower to react with active sites of enzymes than
aprotinin and is very susceptible to spontaneous hydrolysis
and loss of activity (Gebhard et al., 1986).

The activity

of this relatively unstable molecule may have been altered
during use and may contribute to the limited activity.
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TAME failed to mediate any effect against either tumor
targets or &· albicans.

While TAME may inhibit other

proteases it has been specifically shown to inhibit the
release of TNF from rIL-2 activated lymphocytes (Scuderi,
1989), and TNF mediated cytotoxicity (Suffys et al., 1988).
Therefore, TNF most likely is not involved in the mechanism
of growth inhibition of &· albicans.

This was not

unexpected, for previous reports have shown TNF activity
requires a longer time frame for tumor cytotoxic activity
than the short term (four hour) assays utilized in these
studies (Old, 1985; Havell et al., 1988).

Furthermore,

previous studies have failed to demonstrate anti-&. albicans
activity of TNF (Djeu et al., 1988).

The observations with

TAME are consistent with those findings.
Effector cells pretreated and washed of protease
inhibitors failed to alter the normal cytotoxic and
inhibitory activity of rIL-2 activated populations.

These

findings are supported by previous studies (Lavie et al.,
1985).

These findings are also consistent with the model

proposed by Lavie in which surf ace-associated proteolytic
enzymes that are concealed from the external environment
become exposed during cytolysis and participate in target
cell damage (Lavie et al., 1985).

The model and results

suggest that only within the contact microenviroment are the
protease inhibitors active, further implying contact may be
essential to the activity of rIL-2 activated populations.
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This dissertation has demonstrated that

~.

slbicans

growth is inhibited by a population of rIL-2 activated
lymphocytes.

According to Granger and Hobbs (1988),

demonstration of the following criteria are required for
indisputable proof that a cell population functions in
defense against a fungal agent: 1) a recognition step occurs
in which the effector cell forms a conjugate with the target
cell; 2) contact-dependent interaction results in target
cell killing or growth inhibition; 3) purified effector or
cell molecules are cytotoxic or cytostatic for the
microorganism; 4) experimental animals made specifically
deficient in the effector cells show enhanced susceptibility
to the microorganism; and 5) enhanced host susceptibility
can be abrogated by adoptive transfer of effector cells.
By these criteria, several sets of experiments must be
completed prior to absolute proof that rIL-2 activated
populations mediate anti-fungal activity.

Upon the

completion of such studies, the role of rIL-2 activated
populations in
answered.

~-

albicans inhibitory activity will be

Until such time, the function of rIL-2 activated

populations in mediating

c.

albicans growth inhibition

remains speculative.
The definition of the rIL-2 activated population as a
biological activity and/or function against the hyphal phase
of

~.

albicans does not address its immunological nature.

These studies strongly suggest that the rIL-2 activated
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population is not an NK or an activated NK population due to
the failure of these populations to mediate g. albicans
growth inhibition (Figures 1, 2, and 3).

Additionally, rIL-

2 activated lymphocytes expressing NK 1.1 fail to mediate g.
albicans growth inhibition (Figure 11). In contrast, rIL-2
activated populations do possess several characteristics of
rIL-2 activated cytotoxic lymphocytes including; broad
spectrum target cell activity, phenotype, and LGL
morphology.

The phenotypic expression of Thy-1.2+ and ASGM-

1+ within the rIL-2 activated population, and Lyt-2.2+
within the rIL-2 activated population directly parallels LAK
phenotypic expression (Mule et al., 1989).

rIL-2 activated

populations are clearly a lymphokine activated cell
population.

Whether they are a lymphokine activated killer

cell (LAK) population or a subset of LAK is unclear.
However, by essentially any definition, the anti-tumor
activity of the lymphocyte population is LAK (Merluzzi et
al., 1986; Mule et al., 1989).

Various studies have

revealed substantial heterogeneity in LAK cell activity
following activation with rIL-2.

The lytic activity of

various types of LAK and their apparent specificity are
highly dependent upon their state of activation.

rIL-2 may

alter the reactivity of LAK populations, and the high levels
of rIL-2 utilized in this study may induce the g. albicans
growth inhibition.

No reports have previously demonstrated

g. albicans growth inhibition or anti-fungal activity for
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LAK populations.
The data presented in this study are the first to show
that rIL-2 activation of splenocytes results in a population
of lymphocytes capable of affecting the growth of
albicans in vitro.

~.

This study is consistent with previous

investigations (Vecchiarelli et al., 1985; Djeu and
Blanchard, 1987) but demonstrates that higher concentrations
of rIL-2 are required to obtain a splenocyte population
capable of affecting the growth of the fungus in vitro.
Whether this phenomenon functions in vivo, as a form of host
defense, has yet to be established.

It is possible that the

elaboration of rIL-2 or other cytokines and the concomitant
induction of activated lymphocytes may indeed serve as a
line of defense against

~.

albicans.

Protection of the

mammalian host against this form of fungal disease may at
least in part account for the resistance of the C57Bl/6
mouse to challenge with the microorganism.

Furthermore,

these cells may serve as potential effectors during the
development of fungal infections and may be considered as a
possible therapeutic means by which to limit fungal
infections in immunocompromised individuals.
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CONCLUSIONS

1)

Splenocytes activated with rIL-2 inhibit the growth of
fungi, in vitro.

They are cos+ lymphocytes which must

be activated with rIL-2 to exhibit fungal growth
inhibition.

2)

Optimal growth inhibition of fungi is mediated by
intact lymphocytes, through a surface-active, serine
protease.

3)

Growth inhibition of fungi does not appear to be
mediated by natural killer cells or activated natural
killer cells.

4)

~.

albicans growth inhibition by rIL-2 activated cell

populations is associated with enhanced tumoricidal
activity against the NK resistant cell line YAC-1 and
the NK resistant cell line P815, suggesting broad
reactivity for heterogenous targets by rIL-2 activated
cell populations.

5)

The rIL-2 activated population which possess
albicans growth inhibitory activity does not

~.
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necessarily possess anti-P815 activity despite
correlative phenotypic, binding and cell associated
protease susceptibility.
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